primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
103697553,10369755,1,PS,BLINDED EXENATIDE,EXENATIDE,1,UNKNOWN,"UNK UNK, QWK",,,,D,,,,,,POWDER FOR SUSPENSION FOR INJECTION,/wk,2015,Q1,Basal cell carcinoma,,2015,Q1,3,F,20130826.0,20140729.0,20140807,20150126,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-19600022,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,81.0,KG,20150126.0,N,CN,US,DE,2015,Q1,Elderly
103697553,10369755,2,SS,BLINDED EXENATIDE,EXENATIDE,1,UNKNOWN,"UNK UNK, QWK",,,,D,,,,,,POWDER FOR SUSPENSION FOR INJECTION,/wk,2015,Q1,Basal cell carcinoma,,2015,Q1,3,F,20130826.0,20140729.0,20140807,20150126,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-19600022,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,81.0,KG,20150126.0,N,CN,US,DE,2015,Q1,Elderly
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Blood glucose increased,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Burning sensation,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Depression,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Dyspepsia,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Flatulence,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Headache,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Nausea,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Pain in extremity,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
104069065,10406906,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,10MCG(2*1):20MCG  INJECTION:ONGOING  10MCG/DAY,,,,D,,,21773.0,10,UG,,BID,2015,Q1,Vomiting,,2015,Q1,5,F,20140807.0,20150112.0,20140825,20150122,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21311675,BRISTOL MYERS SQUIBB,,58.0,YR,,F,Y,,,20150122.0,N,PH,TR,TR,2015,Q1,Adult
105579703,10557970,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,5MCG(SEP-OCT2014)  10MCG(OCT2014-ONG),,,,D,,,21773.0,10,UG,,BID,2015,Q1,Cerebrovascular accident,,2015,Q1,3,F,20141016.0,20150107.0,20141031,20150117,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21525282,BRISTOL MYERS SQUIBB,,62.0,YR,,M,Y,,,20150117.0,N,CN,CN,CN,2015,Q1,Adult
105579703,10557970,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,5MCG(SEP-OCT2014)  10MCG(OCT2014-ONG),,,,D,,,21773.0,10,UG,,BID,2015,Q1,Hypoglycaemia,,2015,Q1,3,F,20141016.0,20150107.0,20141031,20150117,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21525282,BRISTOL MYERS SQUIBB,,62.0,YR,,M,Y,,,20150117.0,N,CN,CN,CN,2015,Q1,Adult
105695674,10569567,1,PS,EXENATIDE,EXENATIDE,1,UNKNOWN,"UNK UNK, QWK",,,,D,,,22200.0,,,POWDER FOR SUSPENSION FOR INJECTION,/wk,2015,Q1,Pancreatic carcinoma,,2015,Q1,4,F,20130402.0,20141103.0,20141106,20150127,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-18800276,BRISTOL MYERS SQUIBB,,67.0,YR,,M,Y,93.0,KG,20150127.0,N,CN,US,DE,2015,Q1,Elderly
106878691,10687869,11,C,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q1,Urosepsis,,2015,Q1,1,I,20141203.0,20141216.0,20150102,20150102,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-004573,BRISTOL MYERS SQUIBB,,71.0,YR,,M,Y,,,20150102.0,N,CN,US,US,2015,Q1,Elderly
106888641,10688864,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"5 ?G, BID",,,,D,,,21773.0,5,UG,,BID,2015,Q1,Cerebral haemorrhage,,2015,Q1,1,I,2014.0,20141219.0,20150103,20150103,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-004794,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20150103.0,N,CN,CN,CN,2015,Q1,Elderly
106888641,10688864,2,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Cerebral haemorrhage,,2015,Q1,1,I,2014.0,20141219.0,20150103,20150103,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-004794,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20150103.0,N,CN,CN,CN,2015,Q1,Elderly
106889962,10688996,1,PS,BLINDED EXENATIDE,EXENATIDE,1,UNKNOWN,"UNK, QWK",,,,D,,,,,,POWDER FOR SUSPENSION FOR INJECTION,/wk,2015,Q1,Colitis,,2015,Q1,2,F,20140428.0,20150102.0,20150103,20150112,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-005022,BRISTOL MYERS SQUIBB,,83.0,YR,,M,Y,71.0,KG,20150112.0,N,OT,US,US,2015,Q1,Elderly
106889962,10688996,2,SS,BLINDED EXENATIDE,EXENATIDE,1,UNKNOWN,"UNK, QWK",,,,D,,,,,,POWDER FOR SUSPENSION FOR INJECTION,/wk,2015,Q1,Colitis,,2015,Q1,2,F,20140428.0,20150102.0,20150103,20150112,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-005022,BRISTOL MYERS SQUIBB,,83.0,YR,,M,Y,71.0,KG,20150112.0,N,OT,US,US,2015,Q1,Elderly
106962222,10696222,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,21773.0,,,SOLUTION FOR INJECTION,,2015,Q1,Blood glucose increased,,2015,Q1,2,F,20070824.0,20141013.0,20150107,20150107,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-US200709001479,BRISTOL MYERS SQUIBB,,64.0,YR,,F,Y,,,20150107.0,N,MD,US,US,2015,Q1,Adult
106962222,10696222,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,21773.0,,,SOLUTION FOR INJECTION,,2015,Q1,Device misuse,,2015,Q1,2,F,20070824.0,20141013.0,20150107,20150107,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-US200709001479,BRISTOL MYERS SQUIBB,,64.0,YR,,F,Y,,,20150107.0,N,MD,US,US,2015,Q1,Adult
106962222,10696222,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,21773.0,,,SOLUTION FOR INJECTION,,2015,Q1,Drug dose omission,,2015,Q1,2,F,20070824.0,20141013.0,20150107,20150107,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-US200709001479,BRISTOL MYERS SQUIBB,,64.0,YR,,F,Y,,,20150107.0,N,MD,US,US,2015,Q1,Adult
106966102,10696610,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"5 ?G, BID",,,,D,,,21773.0,5,UG,,BID,2015,Q1,Abdominal distension,,2015,Q1,2,F,2014.0,20141225.0,20150107,20150107,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21545595,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20150107.0,N,CN,TR,TR,2015,Q1,Adult
106966102,10696610,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"5 ?G, BID",,,,D,,,21773.0,5,UG,,BID,2015,Q1,Bronchopneumonia,,2015,Q1,2,F,2014.0,20141225.0,20150107,20150107,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21545595,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20150107.0,N,CN,TR,TR,2015,Q1,Adult
106966102,10696610,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"5 ?G, BID",,,,D,,,21773.0,5,UG,,BID,2015,Q1,Constipation,,2015,Q1,2,F,2014.0,20141225.0,20150107,20150107,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21545595,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20150107.0,N,CN,TR,TR,2015,Q1,Adult
106966102,10696610,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"5 ?G, BID",,,,D,,,21773.0,5,UG,,BID,2015,Q1,Dyspepsia,,2015,Q1,2,F,2014.0,20141225.0,20150107,20150107,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21545595,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20150107.0,N,CN,TR,TR,2015,Q1,Adult
106966102,10696610,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"5 ?G, BID",,,,D,,,21773.0,5,UG,,BID,2015,Q1,Hepatic enzyme increased,,2015,Q1,2,F,2014.0,20141225.0,20150107,20150107,EXP,,TR-BRISTOL-MYERS SQUIBB COMPANY-21545595,BRISTOL MYERS SQUIBB,,62.0,YR,,F,Y,,,20150107.0,N,CN,TR,TR,2015,Q1,Adult
106969411,10696941,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Blood glucose decreased,,2015,Q1,1,I,20140610.0,20141208.0,20150108,20150108,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-000236,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20150108.0,N,CN,CN,CN,2015,Q1,Adult
106969411,10696941,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Carbohydrate antigen 19-9 increased,,2015,Q1,1,I,20140610.0,20141208.0,20150108,20150108,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-000236,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20150108.0,N,CN,CN,CN,2015,Q1,Adult
106969411,10696941,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Nausea,,2015,Q1,1,I,20140610.0,20141208.0,20150108,20150108,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-000236,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20150108.0,N,CN,CN,CN,2015,Q1,Adult
106969411,10696941,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Vomiting,,2015,Q1,1,I,20140610.0,20141208.0,20150108,20150108,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-000236,BRISTOL MYERS SQUIBB,,40.0,YR,,M,Y,,,20150108.0,N,CN,CN,CN,2015,Q1,Adult
106988241,10698824,1,PS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,21773.0,,,SOLUTION FOR INJECTION,,2015,Q1,Pancreatic carcinoma metastatic,,2015,Q1,1,I,20110620.0,20141224.0,20150108,20150108,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-006693,BRISTOL MYERS SQUIBB,,66.0,YR,,M,Y,,,20150108.0,N,CN,US,US,2015,Q1,Elderly
107011692,10701169,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Hypoglycaemia,,2015,Q1,2,F,20140903.0,20141230.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21601224,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107011692,10701169,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Impaired gastric emptying,,2015,Q1,2,F,20140903.0,20141230.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21601224,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107011692,10701169,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Myocardial infarction,,2015,Q1,2,F,20140903.0,20141230.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21601224,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107011692,10701169,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Vomiting,,2015,Q1,2,F,20140903.0,20141230.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21601224,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107027092,10702709,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Blood glucose increased,,2015,Q1,2,F,201406.0,20141231.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21671938,BRISTOL MYERS SQUIBB,,53.0,YR,,F,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107027092,10702709,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Carotid arteriosclerosis,,2015,Q1,2,F,201406.0,20141231.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21671938,BRISTOL MYERS SQUIBB,,53.0,YR,,F,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107027092,10702709,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Hypertension,,2015,Q1,2,F,201406.0,20141231.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21671938,BRISTOL MYERS SQUIBB,,53.0,YR,,F,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107027092,10702709,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Left atrial dilatation,,2015,Q1,2,F,201406.0,20141231.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21671938,BRISTOL MYERS SQUIBB,,53.0,YR,,F,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107027092,10702709,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Visual impairment,,2015,Q1,2,F,201406.0,20141231.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21671938,BRISTOL MYERS SQUIBB,,53.0,YR,,F,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107027092,10702709,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,21773.0,10,UG,,BID,2015,Q1,Weight abnormal,,2015,Q1,2,F,201406.0,20141231.0,20150109,20150109,EXP,,CN-BRISTOL-MYERS SQUIBB COMPANY-21671938,BRISTOL MYERS SQUIBB,,53.0,YR,,F,Y,,,20150109.0,N,CN,CN,CN,2015,Q1,Adult
107035923,10703592,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Loss of consciousness,,2015,Q1,3,F,20141128.0,20150108.0,20150112,20150121,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-000257,BRISTOL MYERS SQUIBB,,68.0,YR,,F,Y,,,20150121.0,N,CN,JP,JP,2015,Q1,Elderly
107091151,10709115,2,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,INJECTION,,2015,Q1,Drug hypersensitivity,,2015,Q1,1,I,2010.0,20141230.0,20150114,20150114,EXP,,US-ASTRAZENECA-2015SE03831,ASTRAZENECA,,56.0,YR,,F,Y,,,20150114.0,N,CN,US,US,2015,Q1,Adult
107091151,10709115,2,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,INJECTION,,2015,Q1,Nasopharyngitis,,2015,Q1,1,I,2010.0,20141230.0,20150114,20150114,EXP,,US-ASTRAZENECA-2015SE03831,ASTRAZENECA,,56.0,YR,,F,Y,,,20150114.0,N,CN,US,US,2015,Q1,Adult
107091151,10709115,2,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,,,,INJECTION,,2015,Q1,Off label use,,2015,Q1,1,I,2010.0,20141230.0,20150114,20150114,EXP,,US-ASTRAZENECA-2015SE03831,ASTRAZENECA,,56.0,YR,,F,Y,,,20150114.0,N,CN,US,US,2015,Q1,Adult
107175881,10717588,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,021773,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Arthropathy,,2015,Q1,1,I,20150107.0,20150105.0,20150116,20150116,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-000203,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107175881,10717588,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,021773,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Blood glucose increased,,2015,Q1,1,I,20150107.0,20150105.0,20150116,20150116,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-000203,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107175881,10717588,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,021773,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Dehydration,,2015,Q1,1,I,20150107.0,20150105.0,20150116,20150116,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-000203,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107175881,10717588,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"10 ?G, BID",,,,D,,,021773,10,UG,SOLUTION FOR INJECTION,BID,2015,Q1,Weight decreased,,2015,Q1,1,I,20150107.0,20150105.0,20150116,20150116,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-000203,BRISTOL MYERS SQUIBB,,73.0,YR,,M,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107176071,10717607,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,10,MG,INJECTION,QD,2015,Q1,Erythema,,2015,Q1,1,I,,20141215.0,20150116,20150116,PER,,US-ASTRAZENECA-2015SE02651,ASTRAZENECA,,68.0,YR,,F,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107176071,10717607,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,10,MG,INJECTION,QD,2015,Q1,Pruritus,,2015,Q1,1,I,,20141215.0,20150116,20150116,PER,,US-ASTRAZENECA-2015SE02651,ASTRAZENECA,,68.0,YR,,F,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107176071,10717607,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,10,MG,INJECTION,QD,2015,Q1,Rash,,2015,Q1,1,I,,20141215.0,20150116,20150116,PER,,US-ASTRAZENECA-2015SE02651,ASTRAZENECA,,68.0,YR,,F,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107176071,10717607,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,10,MG,INJECTION,QD,2015,Q1,Skin exfoliation,,2015,Q1,1,I,,20141215.0,20150116,20150116,PER,,US-ASTRAZENECA-2015SE02651,ASTRAZENECA,,68.0,YR,,F,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107176071,10717607,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,10,MG,INJECTION,QD,2015,Q1,Skin haemorrhage,,2015,Q1,1,I,,20141215.0,20150116,20150116,PER,,US-ASTRAZENECA-2015SE02651,ASTRAZENECA,,68.0,YR,,F,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107176071,10717607,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,10,MG,INJECTION,QD,2015,Q1,Skin injury,,2015,Q1,1,I,,20141215.0,20150116,20150116,PER,,US-ASTRAZENECA-2015SE02651,ASTRAZENECA,,68.0,YR,,F,Y,,,20150116.0,N,CN,US,US,2015,Q1,Elderly
107181591,10718159,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,?,10.0,MG,,D, AAA1391,,,2,MG,INJECTION,/wk,2015,Q1,Drug dose omission,,2015,Q1,1,I,20141215.0,20141217.0,20150118,20150118,PER,,US-ASTRAZENECA-2015SE02842,ASTRAZENECA,,67.0,YR,,F,Y,,,20150118.0,N,CN,US,US,2015,Q1,Elderly
107181591,10718159,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,?,10.0,MG,,D, AAA1391,,,2,MG,INJECTION,/wk,2015,Q1,Injection site bruising,,2015,Q1,1,I,20141215.0,20141217.0,20150118,20150118,PER,,US-ASTRAZENECA-2015SE02842,ASTRAZENECA,,67.0,YR,,F,Y,,,20150118.0,N,CN,US,US,2015,Q1,Elderly
107181591,10718159,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,?,10.0,MG,,D, AAA1391,,,2,MG,INJECTION,/wk,2015,Q1,Injection site extravasation,,2015,Q1,1,I,20141215.0,20141217.0,20150118,20150118,PER,,US-ASTRAZENECA-2015SE02842,ASTRAZENECA,,67.0,YR,,F,Y,,,20150118.0,N,CN,US,US,2015,Q1,Elderly
107181591,10718159,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,?,10.0,MG,,D, AAA1391,,,2,MG,INJECTION,/wk,2015,Q1,Injection site haemorrhage,,2015,Q1,1,I,20141215.0,20141217.0,20150118,20150118,PER,,US-ASTRAZENECA-2015SE02842,ASTRAZENECA,,67.0,YR,,F,Y,,,20150118.0,N,CN,US,US,2015,Q1,Elderly
107236101,10723610,1,PS,EXENATIDE,EXENATIDE,1,,,,,D,D,,,,,,,,2015,Q1,Abdominal pain upper,,2015,Q1,1,I,20120522.0,,20150116,20150116,DIR,,,,,72.0,YR,,F,N,,,20150115.0,N,,US,,2015,Q1,Elderly
107236101,10723610,1,PS,EXENATIDE,EXENATIDE,1,,,,,D,D,,,,,,,,2015,Q1,Pancreatic duct dilatation,,2015,Q1,1,I,20120522.0,,20150116,20150116,DIR,,,,,72.0,YR,,F,N,,,20150115.0,N,,US,,2015,Q1,Elderly
107236101,10723610,1,PS,EXENATIDE,EXENATIDE,1,,,,,D,D,,,,,,,,2015,Q1,Pancreatitis,,2015,Q1,1,I,20120522.0,,20150116,20150116,DIR,,,,,72.0,YR,,F,N,,,20150115.0,N,,US,,2015,Q1,Elderly
107342181,10734218,1,PS,EXENATIDE,EXENATIDE,1,UNKNOWN,UNK,,,,D,,,21773.0,,,SOLUTION FOR INJECTION,,2015,Q1,Dyspnoea,,2015,Q1,1,I,20150108.0,20150109.0,20150123,20150123,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-002433,BRISTOL MYERS SQUIBB,,76.0,YR,,M,Y,101.0,KG,20150123.0,N,CN,CA,CA,2015,Q1,Elderly
107351651,10735165,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"UNK, QWK",2.2079999,MG,,D,,,21773.0,2,MG,,/wk,2015,Q1,Acetonaemia,,2015,Q1,1,I,20141218.0,20141218.0,20150125,20150125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-005065,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,51.0,KG,20150125.0,N,CN,JP,JP,2015,Q1,Elderly
107351651,10735165,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"UNK, QWK",2.2079999,MG,,D,,,21773.0,2,MG,,/wk,2015,Q1,Diabetic hyperglycaemic coma,,2015,Q1,1,I,20141218.0,20141218.0,20150125,20150125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-005065,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,51.0,KG,20150125.0,N,CN,JP,JP,2015,Q1,Elderly
107351651,10735165,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"UNK, QWK",2.2079999,MG,,D,,,21773.0,2,MG,,/wk,2015,Q1,Malaise,,2015,Q1,1,I,20141218.0,20141218.0,20150125,20150125,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-005065,BRISTOL MYERS SQUIBB,,84.0,YR,,F,Y,51.0,KG,20150125.0,N,CN,JP,JP,2015,Q1,Elderly
107351681,10735168,1,PS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,21773.0,,,,,2015,Q1,Pancreatic carcinoma metastatic,,2015,Q1,1,I,201101.0,20150115.0,20150125,20150125,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-004091,BRISTOL MYERS SQUIBB,,51.0,YR,,F,Y,59.1,KG,20150125.0,N,CN,US,US,2015,Q1,Adult
107353691,10735369,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D, AM140015,,,10,UG,INJECTION,BID,2015,Q1,Blood glucose increased,,2015,Q1,1,I,,20150116.0,20150125,20150125,PER,,US-ASTRAZENECA-2015SE07180,ASTRAZENECA,,68.0,YR,,M,Y,,,20150126.0,N,CN,US,US,2015,Q1,Elderly
107370971,10737097,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D, AM140021,,21919.0,10,UG,INJECTION,BID,2015,Q1,Blood glucose increased,,2015,Q1,1,I,,20150115.0,20150126,20150126,PER,,US-ASTRAZENECA-2015SE07155,ASTRAZENECA,,66.0,YR,,M,Y,,,20150126.0,N,CN,US,US,2015,Q1,Elderly
107394542,10739454,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,"UNK UNK, QWK",,,,D,,,21773.0,,,SOLUTION FOR INJECTION,/wk,2015,Q1,Angina unstable,,2015,Q1,2,F,20141220.0,20150108.0,20150126,20150127,EXP,,PL-BRISTOL-MYERS SQUIBB COMPANY-BMS-2014-006285,BRISTOL MYERS SQUIBB,,62.0,YR,,M,Y,90.0,KG,20150127.0,N,CN,PL,PL,2015,Q1,Adult
107449231,10744923,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,2.0,MG,,D,,,,2,MG,INJECTION,/wk,2015,Q1,Diarrhoea,,2015,Q1,1,I,20150108.0,20150113.0,20150128,20150128,PER,,US-ASTRAZENECA-2015SE06825,ASTRAZENECA,,59.0,YR,,M,Y,,,20150128.0,N,CN,US,US,2015,Q1,Adult
107449231,10744923,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,2.0,MG,,D,,,,2,MG,INJECTION,/wk,2015,Q1,Fatigue,,2015,Q1,1,I,20150108.0,20150113.0,20150128,20150128,PER,,US-ASTRAZENECA-2015SE06825,ASTRAZENECA,,59.0,YR,,M,Y,,,20150128.0,N,CN,US,US,2015,Q1,Adult
107449231,10744923,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,2.0,MG,,D,,,,2,MG,INJECTION,/wk,2015,Q1,Overdose,,2015,Q1,1,I,20150108.0,20150113.0,20150128,20150128,PER,,US-ASTRAZENECA-2015SE06825,ASTRAZENECA,,59.0,YR,,M,Y,,,20150128.0,N,CN,US,US,2015,Q1,Adult
107460951,10746095,1,PS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Pancreatic carcinoma metastatic,,2015,Q1,1,I,201101.0,20150115.0,20150128,20150128,EXP,,US-ASTRAZENECA-2015SE07834,ASTRAZENECA,,52.0,YR,,F,Y,,,20150128.0,N,CN,US,US,2015,Q1,Adult
107548001,10754800,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,Y,D,,,,10,UG,,BID,2015,Q1,Nausea,,2015,Q1,1,I,20150119.0,,20150130,20150130,DIR,,,,,61.0,YR,,M,N,175.5,KG,20150129.0,N,PH,US,,2015,Q1,Adult
107548001,10754800,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,Y,D,,,,10,UG,,BID,2015,Q1,Pancreatitis,,2015,Q1,1,I,20150119.0,,20150130,20150130,DIR,,,,,61.0,YR,,M,N,175.5,KG,20150129.0,N,PH,US,,2015,Q1,Adult
108698751,10869875,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Constipation,,2015,Q1,1,I,2007.0,20080131.0,20150226,20150226,PER,,US-ASTRAZENECA-2013SE63424,ASTRAZENECA,,56.0,YR,,M,Y,108.9,KG,20150226.0,N,,US,US,2015,Q1,Adult
108698751,10869875,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Decreased appetite,,2015,Q1,1,I,2007.0,20080131.0,20150226,20150226,PER,,US-ASTRAZENECA-2013SE63424,ASTRAZENECA,,56.0,YR,,M,Y,108.9,KG,20150226.0,N,,US,US,2015,Q1,Adult
108698751,10869875,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Drug ineffective,,2015,Q1,1,I,2007.0,20080131.0,20150226,20150226,PER,,US-ASTRAZENECA-2013SE63424,ASTRAZENECA,,56.0,YR,,M,Y,108.9,KG,20150226.0,N,,US,US,2015,Q1,Adult
108698751,10869875,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Injection site erythema,,2015,Q1,1,I,2007.0,20080131.0,20150226,20150226,PER,,US-ASTRAZENECA-2013SE63424,ASTRAZENECA,,56.0,YR,,M,Y,108.9,KG,20150226.0,N,,US,US,2015,Q1,Adult
108698751,10869875,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Injection site extravasation,,2015,Q1,1,I,2007.0,20080131.0,20150226,20150226,PER,,US-ASTRAZENECA-2013SE63424,ASTRAZENECA,,56.0,YR,,M,Y,108.9,KG,20150226.0,N,,US,US,2015,Q1,Adult
108698751,10869875,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Injection site haemorrhage,,2015,Q1,1,I,2007.0,20080131.0,20150226,20150226,PER,,US-ASTRAZENECA-2013SE63424,ASTRAZENECA,,56.0,YR,,M,Y,108.9,KG,20150226.0,N,,US,US,2015,Q1,Adult
108698751,10869875,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Injection site pain,,2015,Q1,1,I,2007.0,20080131.0,20150226,20150226,PER,,US-ASTRAZENECA-2013SE63424,ASTRAZENECA,,56.0,YR,,M,Y,108.9,KG,20150226.0,N,,US,US,2015,Q1,Adult
108806031,10880603,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Acute kidney injury,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INVENTIA-000026,INVENTIA HEALTHCARE,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806031,10880603,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Dehydration,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INVENTIA-000026,INVENTIA HEALTHCARE,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806031,10880603,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Drug intolerance,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INVENTIA-000026,INVENTIA HEALTHCARE,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806031,10880603,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Lactic acidosis,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INVENTIA-000026,INVENTIA HEALTHCARE,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806031,10880603,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Pancreatitis,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INVENTIA-000026,INVENTIA HEALTHCARE,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806111,10880611,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Acute kidney injury,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INDICUS PHARMA-000312,INDICUS,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806111,10880611,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Lactic acidosis,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INDICUS PHARMA-000312,INDICUS,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806111,10880611,3,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Pancreatitis,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-INDICUS PHARMA-000312,INDICUS,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806171,10880617,2,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Acute kidney injury,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-ALKEM-000895,ALKEM,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806171,10880617,2,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Lactic acidosis,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-ALKEM-000895,ALKEM,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
108806171,10880617,2,SS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,,5,UG,INJECTION,BID,2015,Q1,Pancreatitis,,2015,Q1,1,I,,20150216.0,20150303,20150303,EXP,,AE-ALKEM-000895,ALKEM,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL ABBOTTABAD. 2014 OCT-DEC;26(4):636-9.",47.0,YR,,F,Y,,,20150303.0,N,MD,AE,AE,2015,Q1,Adult
109042571,10904257,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,,,,D,,,21773.0,10,UG,INJECTION,BID,2015,Q1,Pancreatic pseudocyst,,2015,Q1,1,I,20150211.0,20150303.0,20150311,20150311,EXP,,GB-ASTRAZENECA-2015SE20744,ASTRAZENECA,,74.0,YR,,F,Y,,,20150311.0,N,OT,GB,GB,2015,Q1,Elderly
109134461,10913446,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Back injury,,2015,Q1,1,I,200812.0,20081215.0,20150313,20150313,PER,,US-ASTRAZENECA-2008BM17286,ASTRAZENECA,,26131.0,DY,,M,Y,79.4,KG,20150313.0,N,CN,US,US,2015,Q1,Elderly
109134461,10913446,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Injection site rash,,2015,Q1,1,I,200812.0,20081215.0,20150313,20150313,PER,,US-ASTRAZENECA-2008BM17286,ASTRAZENECA,,26131.0,DY,,M,Y,79.4,KG,20150313.0,N,CN,US,US,2015,Q1,Elderly
109134461,10913446,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q1,Protein urine present,,2015,Q1,1,I,200812.0,20081215.0,20150313,20150313,PER,,US-ASTRAZENECA-2008BM17286,ASTRAZENECA,,26131.0,DY,,M,Y,79.4,KG,20150313.0,N,CN,US,US,2015,Q1,Elderly
109203081,10920308,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Abdominal distension,,2015,Q1,1,I,200704.0,20070710.0,20150317,20150317,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150317.0,N,,US,US,2015,Q1,Adult
109203081,10920308,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Blood glucose abnormal,,2015,Q1,1,I,200704.0,20070710.0,20150317,20150317,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150317.0,N,,US,US,2015,Q1,Adult
109203081,10920308,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Blood glucose decreased,,2015,Q1,1,I,200704.0,20070710.0,20150317,20150317,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150317.0,N,,US,US,2015,Q1,Adult
109203081,10920308,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Device misuse,,2015,Q1,1,I,200704.0,20070710.0,20150317,20150317,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150317.0,N,,US,US,2015,Q1,Adult
109203081,10920308,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Drug effect decreased,,2015,Q1,1,I,200704.0,20070710.0,20150317,20150317,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150317.0,N,,US,US,2015,Q1,Adult
109203081,10920308,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Intentional product misuse,,2015,Q1,1,I,200704.0,20070710.0,20150317,20150317,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150317.0,N,,US,US,2015,Q1,Adult
109203081,10920308,3,SS,EXENATIDE,EXENATIDE,1,UNKNOWN,,,,,D,,,,,,INJECTION,,2015,Q1,Weight decreased,,2015,Q1,1,I,200704.0,20070710.0,20150317,20150317,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150317.0,N,,US,US,2015,Q1,Adult
109263101,10926310,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Dyspnoea,,2015,Q1,1,I,20120629.0,20120711.0,20150202,20150202,PER,,TPA2012A04369,TAKEDA,,73.0,YR,,F,N,,,20130208.0,N,MD,US,,2015,Q1,Elderly
109263101,10926310,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Erythema,,2015,Q1,1,I,20120629.0,20120711.0,20150202,20150202,PER,,TPA2012A04369,TAKEDA,,73.0,YR,,F,N,,,20130208.0,N,MD,US,,2015,Q1,Elderly
109263101,10926310,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Fatigue,,2015,Q1,1,I,20120629.0,20120711.0,20150202,20150202,PER,,TPA2012A04369,TAKEDA,,73.0,YR,,F,N,,,20130208.0,N,MD,US,,2015,Q1,Elderly
109263101,10926310,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Nausea,,2015,Q1,1,I,20120629.0,20120711.0,20150202,20150202,PER,,TPA2012A04369,TAKEDA,,73.0,YR,,F,N,,,20130208.0,N,MD,US,,2015,Q1,Elderly
109263101,10926310,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Urticaria,,2015,Q1,1,I,20120629.0,20120711.0,20150202,20150202,PER,,TPA2012A04369,TAKEDA,,73.0,YR,,F,N,,,20130208.0,N,MD,US,,2015,Q1,Elderly
109263101,10926310,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Wheezing,,2015,Q1,1,I,20120629.0,20120711.0,20150202,20150202,PER,,TPA2012A04369,TAKEDA,,73.0,YR,,F,N,,,20130208.0,N,MD,US,,2015,Q1,Elderly
109502951,10950295,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,14610.0,UG,,D,,,,5,UG,INJECTION,BID,2015,Q1,Bullous lung disease,,2015,Q1,1,I,20081109.0,20150316.0,20150324,20150324,EXP,,JP-ASTRAZENECA-2015SE24774,ASTRAZENECA,,66.0,YR,,M,Y,,,20150324.0,N,MD,JP,JP,2015,Q1,Elderly
109502951,10950295,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,14610.0,UG,,D,,,,5,UG,INJECTION,BID,2015,Q1,Metastases to liver,,2015,Q1,1,I,20081109.0,20150316.0,20150324,20150324,EXP,,JP-ASTRAZENECA-2015SE24774,ASTRAZENECA,,66.0,YR,,M,Y,,,20150324.0,N,MD,JP,JP,2015,Q1,Elderly
109502951,10950295,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,14610.0,UG,,D,,,,5,UG,INJECTION,BID,2015,Q1,Pancreatic carcinoma stage IV,,2015,Q1,1,I,20081109.0,20150316.0,20150324,20150324,EXP,,JP-ASTRAZENECA-2015SE24774,ASTRAZENECA,,66.0,YR,,M,Y,,,20150324.0,N,MD,JP,JP,2015,Q1,Elderly
109502951,10950295,1,PS,EXENATIDE,EXENATIDE,1,SUBCUTANEOUS,,14610.0,UG,,D,,,,5,UG,INJECTION,BID,2015,Q1,Pancreatitis acute,,2015,Q1,1,I,20081109.0,20150316.0,20150324,20150324,EXP,,JP-ASTRAZENECA-2015SE24774,ASTRAZENECA,,66.0,YR,,M,Y,,,20150324.0,N,MD,JP,JP,2015,Q1,Elderly
109509151,10950915,7,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Oedema peripheral,,2015,Q1,1,I,20110915.0,20130222.0,20150226,20150226,PER,,TPA2013A01680,TAKEDA,,40.0,YR,,F,N,,,20130822.0,N,,US,,2015,Q1,Adult
109509641,10950964,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20080211.0,20120731.0,20150226,20150226,PER,,TPA2012A03481,TAKEDA,,63.0,YR,,M,N,,,20121017.0,N,,US,,2015,Q1,Adult
109509641,10950964,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q1,Depression,,2015,Q1,1,I,20080211.0,20120731.0,20150226,20150226,PER,,TPA2012A03481,TAKEDA,,63.0,YR,,M,N,,,20121017.0,N,,US,,2015,Q1,Adult
109509641,10950964,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q1,Urinary retention,,2015,Q1,1,I,20080211.0,20120731.0,20150226,20150226,PER,,TPA2012A03481,TAKEDA,,63.0,YR,,M,N,,,20121017.0,N,,US,,2015,Q1,Adult
109509801,10950980,4,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20090501.0,20120726.0,20150226,20150226,PER,,TPA2012A05016,TAKEDA,,58.0,YR,,M,N,180.0,LBS,20121017.0,N,,US,,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Blood bicarbonate decreased,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Blood lactic acid increased,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Blood pH decreased,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Dehydration,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Drug level increased,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Hypoglycaemia,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Lactic acidosis,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109532301,10953230,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,QD,2015,Q1,Metabolic acidosis,,2015,Q1,1,I,,20150318.0,20150325,20150325,EXP,,JP-SA-2015SA035905,AVENTIS,"NISHIHAMA K, OZAKI K, OKANO Y, HOTTA Y, HASHIMOTO R, UEMURA M, ET AL. A CASE OF LACTIC ACIDOSIS WHOSE CAUSE IS CONSIDERED TO BE METFORMIN, SHOWING HYPOGLYCAEMIA. THE 225TH TOKAI CONGRESS OF THE JAPANESE SOCIETY OF INTERNAL MEDICINE; 2015 FEB 22; TSU CITY, MIE PREFECTURE, JAPAN. JOURNAL:UNKNOWN",64.0,YR,A,F,Y,,,20150325.0,N,MD,JP,JP,2015,Q1,Adult
109557661,10955766,9,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer recurrent,,2015,Q1,1,I,20080108.0,20121106.0,20150226,20150226,PER,,TPA2012A02948,TAKEDA,,56.0,YR,,M,N,290.0,LBS,20130829.0,N,OT,US,,2015,Q1,Adult
109559431,10955943,11,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20080508.0,20130103.0,20150226,20150226,PER,,TPA2012A09362,TAKEDA,,66.0,YR,,F,N,240.0,LBS,20130829.0,N,,US,,2015,Q1,Elderly
109561551,10956155,20,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,200905.0,20130725.0,20150226,20150226,PER,,TPA2013A03387,TAKEDA,,75.0,YR,,M,N,200.0,LBS,20130829.0,N,,US,,2015,Q1,Elderly
109562361,10956236,10,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20100407.0,20121022.0,20150226,20150226,PER,,TPA2012A08583,TAKEDA,,71.0,YR,,M,N,214.0,LBS,20130829.0,N,CN,US,,2015,Q1,Elderly
109567951,10956795,13,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20111108.0,20140828.0,20150226,20150226,PER,,TPA2013A07533,TAKEDA,,72.0,YR,,M,N,81.6,KG,20140929.0,N,OT,US,,2015,Q1,Elderly
109611991,10961199,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20090810.0,20120731.0,20150226,20150226,PER,,TPA2012A01948,TAKEDA,,70.0,YR,,F,N,167.0,LBS,20120918.0,N,OT,US,,2015,Q1,Elderly
109611991,10961199,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q1,Cystitis,,2015,Q1,1,I,20090810.0,20120731.0,20150226,20150226,PER,,TPA2012A01948,TAKEDA,,70.0,YR,,F,N,167.0,LBS,20120918.0,N,OT,US,,2015,Q1,Elderly
109766971,10976697,19,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20080611.0,20140820.0,20150226,20150226,PER,,TPA2013A07486,TAKEDA,,63.0,YR,,M,N,103.4,KG,20140929.0,N,,US,,2015,Q1,Adult
109767221,10976722,9,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20071024.0,20140828.0,20150226,20150226,PER,,TPA2013A07460,TAKEDA,,69.0,YR,,M,N,87.1,KG,20140929.0,N,OT,US,,2015,Q1,Elderly
109767311,10976731,6,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Abdominal pain,,2015,Q1,1,I,2013.0,,20150226,20150226,PER,,2013TUS001925,TAKEDA,,71.0,YR,,M,N,,,20140929.0,N,,US,,2015,Q1,Elderly
109767311,10976731,6,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder transitional cell carcinoma,,2015,Q1,1,I,2013.0,,20150226,20150226,PER,,2013TUS001925,TAKEDA,,71.0,YR,,M,N,,,20140929.0,N,,US,,2015,Q1,Elderly
109767311,10976731,6,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Pollakiuria,,2015,Q1,1,I,2013.0,,20150226,20150226,PER,,2013TUS001925,TAKEDA,,71.0,YR,,M,N,,,20140929.0,N,,US,,2015,Q1,Elderly
109791461,10979146,5,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,20100902.0,20130801.0,20150226,20150226,PER,,TPA2013A04990,TAKEDA,,80.0,YR,,M,N,,,20140929.0,N,OT,US,,2015,Q1,Elderly
109792421,10979242,13,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,200711.0,20130808.0,20150226,20150226,PER,,TPA2013A04377,TAKEDA,,70.0,YR,,M,N,,,20140929.0,N,OT,US,,2015,Q1,Elderly
109792711,10979271,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder transitional cell carcinoma,,2015,Q1,1,I,20030611.0,20130805.0,20150226,20150226,PER,,TPA2013A04825,TAKEDA,,52.0,YR,,M,N,111.1,KG,20140929.0,N,OT,US,,2015,Q1,Adult
109792711,10979271,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Cystitis,,2015,Q1,1,I,20030611.0,20130805.0,20150226,20150226,PER,,TPA2013A04825,TAKEDA,,52.0,YR,,M,N,111.1,KG,20140929.0,N,OT,US,,2015,Q1,Adult
109902831,10990283,14,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,1,I,200709.0,20120731.0,20150226,20150226,PER,,TPA2012A01307,TAKEDA,,63.0,YR,,M,N,250.0,LBS,20120918.0,N,MD,US,,2015,Q1,Adult
109902831,10990283,14,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Cystitis,,2015,Q1,1,I,200709.0,20120731.0,20150226,20150226,PER,,TPA2012A01307,TAKEDA,,63.0,YR,,M,N,250.0,LBS,20120918.0,N,MD,US,,2015,Q1,Adult
109902831,10990283,14,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Urinary tract infection,,2015,Q1,1,I,200709.0,20120731.0,20150226,20150226,PER,,TPA2012A01307,TAKEDA,,63.0,YR,,M,N,250.0,LBS,20120918.0,N,MD,US,,2015,Q1,Adult
82838532,8283853,3,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q1,Bladder cancer,,2015,Q1,2,F,20080103.0,20121031.0,20111205,20150226,PER,,TPA2011A07869,TAKEDA,,50.0,YR,,M,N,230.0,LBS,20130829.0,,OT,US,,2015,Q1,Adult
102133283,10213328,19,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q2,Dyspnoea,,2015,Q2,3,F,20140515.0,20150511.0,20140529,20150520,EXP,,UNT-2014-000882,UNITED THERAPEUTICS,,62.0,YR,,F,N,,,20150519.0,N,MD,US,,2015,Q2,Adult
105690417,10569041,7,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,,2015,Q2,Myocardial ischaemia,,2015,Q2,7,F,20140916.0,20150408.0,20141106,20150417,EXP,,BE-JNJFOC-20141017691,JANSSEN,,55.0,YR,A,M,Y,99.0,KG,20150417.0,N,MD,BE,BE,2015,Q2,Adult
105690417,10569041,7,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,20,UG,,,2015,Q2,Scan myocardial perfusion abnormal,,2015,Q2,7,F,20140916.0,20150408.0,20141106,20150417,EXP,,BE-JNJFOC-20141017691,JANSSEN,,55.0,YR,A,M,Y,99.0,KG,20150417.0,N,MD,BE,BE,2015,Q2,Adult
108748114,10874811,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Chronic gastritis,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Duodenitis haemorrhagic,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Gastrooesophageal reflux disease,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Hiatus hernia,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Small intestinal haemorrhage,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,2,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Chronic gastritis,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,2,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Duodenitis haemorrhagic,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,2,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Gastrooesophageal reflux disease,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,2,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Hiatus hernia,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
108748114,10874811,2,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE A WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Small intestinal haemorrhage,,2015,Q2,4,F,20141209.0,20150416.0,20150227,20150424,EXP,,BG-ASTRAZENECA-2015SE17310,ASTRAZENECA,,72.0,YR,,M,Y,88.0,KG,20150424.0,N,MD,BG,BG,2015,Q2,Elderly
109411942,10941194,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q2,Hypotension,,2015,Q2,2,F,201406.0,20140915.0,20150322,20150524,PER,,US-JNJFOC-20140703654,JANSSEN,,45.0,YR,A,M,Y,,,20150524.0,N,MD,US,US,2015,Q2,Adult
109424762,10942476,4,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Glycosylated haemoglobin decreased,,2015,Q2,2,F,20140706.0,20140716.0,20150322,20150524,PER,,US-JNJFOC-20140711315,JANSSEN,,64.0,YR,A,M,Y,76.2,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109424762,10942476,4,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Polydipsia,,2015,Q2,2,F,20140706.0,20140716.0,20150322,20150524,PER,,US-JNJFOC-20140711315,JANSSEN,,64.0,YR,A,M,Y,76.2,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109424762,10942476,4,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Polyuria,,2015,Q2,2,F,20140706.0,20140716.0,20150322,20150524,PER,,US-JNJFOC-20140711315,JANSSEN,,64.0,YR,A,M,Y,76.2,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109424762,10942476,4,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Weight decreased,,2015,Q2,2,F,20140706.0,20140716.0,20150322,20150524,PER,,US-JNJFOC-20140711315,JANSSEN,,64.0,YR,A,M,Y,76.2,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109424762,10942476,4,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Wrong technique in drug usage process,,2015,Q2,2,F,20140706.0,20140716.0,20150322,20150524,PER,,US-JNJFOC-20140711315,JANSSEN,,64.0,YR,A,M,Y,76.2,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
109425082,10942508,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q2,Fungal infection,,2015,Q2,2,F,,20130617.0,20150322,20150524,PER,,US-JNJFOC-20130611164,JANSSEN,,5.0,DEC,A,F,Y,,,20150524.0,N,MD,US,US,2015,Q2,Child
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Ageusia,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Anaemia,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Blood glucose decreased,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Blood glucose increased,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Body height decreased,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Chronic obstructive pulmonary disease,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Contusion,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Cough,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Dyspepsia,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Dysphonia,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Eating disorder,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Gastrooesophageal reflux disease,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Glycosylated haemoglobin increased,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Hiatus hernia,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Intentional product misuse,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Iron deficiency,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Macular oedema,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Nasopharyngitis,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Off label use,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Pollakiuria,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Rhinorrhoea,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Somnolence,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Thirst,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Throat irritation,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Visual acuity reduced,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Weight decreased,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109747942,10974794,6,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,INJECTION,,2015,Q2,Weight increased,,2015,Q2,2,F,2000.0,20150319.0,20150401,20150608,PER,,US-ASTRAZENECA-2008BM07837,ASTRAZENECA,,57.0,YR,,F,Y,72.6,KG,20150608.0,N,CN,US,US,2015,Q2,Adult
109771491,10977149,4,C,EXENATIDE,EXENATIDE,1,,10MCG PEN,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Drug dose omission,,2015,Q2,1,I,200604.0,20060419.0,20150402,20150402,PER,,US-ASTRAZENECA-2006BM06220,ASTRAZENECA,,735.0,MON,,F,Y,81.6,KG,20150402.0,N,,US,US,2015,Q2,Elderly
109771491,10977149,4,C,EXENATIDE,EXENATIDE,1,,10MCG PEN,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Intentional product misuse,,2015,Q2,1,I,200604.0,20060419.0,20150402,20150402,PER,,US-ASTRAZENECA-2006BM06220,ASTRAZENECA,,735.0,MON,,F,Y,81.6,KG,20150402.0,N,,US,US,2015,Q2,Elderly
109771491,10977149,4,C,EXENATIDE,EXENATIDE,1,,10MCG PEN,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Therapeutic response unexpected,,2015,Q2,1,I,200604.0,20060419.0,20150402,20150402,PER,,US-ASTRAZENECA-2006BM06220,ASTRAZENECA,,735.0,MON,,F,Y,81.6,KG,20150402.0,N,,US,US,2015,Q2,Elderly
109771491,10977149,4,C,EXENATIDE,EXENATIDE,1,,10MCG PEN,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Vision blurred,,2015,Q2,1,I,200604.0,20060419.0,20150402,20150402,PER,,US-ASTRAZENECA-2006BM06220,ASTRAZENECA,,735.0,MON,,F,Y,81.6,KG,20150402.0,N,,US,US,2015,Q2,Elderly
109771491,10977149,4,C,EXENATIDE,EXENATIDE,1,,10MCG PEN,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Weight decreased,,2015,Q2,1,I,200604.0,20060419.0,20150402,20150402,PER,,US-ASTRAZENECA-2006BM06220,ASTRAZENECA,,735.0,MON,,F,Y,81.6,KG,20150402.0,N,,US,US,2015,Q2,Elderly
109849881,10984988,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,10,UG,INJECTION,,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20140523.0,20150326.0,20150403,20150403,EXP,,GB-ASTRAZENECA-2015SE28858,ASTRAZENECA,,70.0,YR,,M,Y,,,20150403.0,N,OT,GB,GB,2015,Q2,Elderly
109849881,10984988,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,10,UG,INJECTION,,2015,Q2,Tubulointerstitial nephritis,,2015,Q2,1,I,20140523.0,20150326.0,20150403,20150403,EXP,,GB-ASTRAZENECA-2015SE28858,ASTRAZENECA,,70.0,YR,,M,Y,,,20150403.0,N,OT,GB,GB,2015,Q2,Elderly
109939521,10993952,3,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q2,Incorrect dose administered,,2015,Q2,1,I,2007.0,20070917.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,55.0,YR,,F,Y,85.7,KG,20150407.0,N,,US,US,2015,Q2,Adult
109939521,10993952,3,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q2,Increased appetite,,2015,Q2,1,I,2007.0,20070917.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,55.0,YR,,F,Y,85.7,KG,20150407.0,N,,US,US,2015,Q2,Adult
109939521,10993952,3,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q2,Injection site nodule,,2015,Q2,1,I,2007.0,20070917.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,55.0,YR,,F,Y,85.7,KG,20150407.0,N,,US,US,2015,Q2,Adult
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Eye disorder,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Injection site bruising,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Injection site erythema,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Injection site haemorrhage,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Injection site mass,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Muscle spasms,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Varicose vein,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
109941791,10994179,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Visual impairment,,2015,Q2,1,I,2006.0,20070601.0,20150407,20150407,PER,,US-ASTRAZENECA-2007BM08696,ASTRAZENECA,,66.0,YR,,F,Y,63.5,KG,20150407.0,N,CN,US,US,2015,Q2,Elderly
110061731,11006173,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,2,MG,INJECTION,/wk,2015,Q2,Pancreatitis,,2015,Q2,1,I,20130722.0,20130805.0,20150409,20150409,EXP,,US-ASTRAZENECA-2013SE64092,ASTRAZENECA,,61.0,YR,,M,Y,111.6,KG,20150409.0,N,CN,US,US,2015,Q2,Adult
110110351,11011035,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,4599.167,UG,,D,,,21773.0,10,UG,INJECTION,BID,2015,Q2,Acute kidney injury,,2015,Q2,1,I,20140801.0,20150403.0,20150410,20150410,EXP,,GB-ASTRAZENECA-2015SE31808,ASTRAZENECA,,51.0,YR,,F,Y,120.0,KG,20150410.0,N,MD,GB,GB,2015,Q2,Adult
110110351,11011035,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,4599.167,UG,,D,,,21773.0,10,UG,INJECTION,BID,2015,Q2,Tubulointerstitial nephritis,,2015,Q2,1,I,20140801.0,20150403.0,20150410,20150410,EXP,,GB-ASTRAZENECA-2015SE31808,ASTRAZENECA,,51.0,YR,,F,Y,120.0,KG,20150410.0,N,MD,GB,GB,2015,Q2,Adult
110201691,11020169,3,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 ?G, 2 /DAY",,,,D,,,,5,UG,,BID,2015,Q2,Acute kidney injury,,2015,Q2,1,I,,20150331.0,20150413,20150413,EXP,,"AE-IMPAX LABORATORIES, INC-2015-IPXL-00377",IMPAX,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A.. EXENATIDE INDUCED ACUTE KIDNEY INJURY. JOURNAL OF AYUB MEDICAL COLLEGE. 2014;26(4):636-9",47.0,YR,,F,Y,,,20150413.0,N,MD,AE,AE,2015,Q2,Adult
110201691,11020169,3,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 ?G, 2 /DAY",,,,D,,,,5,UG,,BID,2015,Q2,Hypotension,,2015,Q2,1,I,,20150331.0,20150413,20150413,EXP,,"AE-IMPAX LABORATORIES, INC-2015-IPXL-00377",IMPAX,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A.. EXENATIDE INDUCED ACUTE KIDNEY INJURY. JOURNAL OF AYUB MEDICAL COLLEGE. 2014;26(4):636-9",47.0,YR,,F,Y,,,20150413.0,N,MD,AE,AE,2015,Q2,Adult
110201691,11020169,3,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 ?G, 2 /DAY",,,,D,,,,5,UG,,BID,2015,Q2,Lactic acidosis,,2015,Q2,1,I,,20150331.0,20150413,20150413,EXP,,"AE-IMPAX LABORATORIES, INC-2015-IPXL-00377",IMPAX,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A.. EXENATIDE INDUCED ACUTE KIDNEY INJURY. JOURNAL OF AYUB MEDICAL COLLEGE. 2014;26(4):636-9",47.0,YR,,F,Y,,,20150413.0,N,MD,AE,AE,2015,Q2,Adult
110210901,11021090,1,PS,Exenatide,EXENATIDE,1,Subcutaneous,"5 ?G, BID",,,,D,,,,5,UG,,Q12H,2015,Q2,Acute kidney injury,,2015,Q2,1,I,,20150330.0,20150413,20150413,EXP,,AE-SUN PHARMACEUTICAL INDUSTRIES LTD-2015R1-95580,RANBAXY,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL. 2014;OCT;26(4):636?9",47.0,YR,,F,Y,,,20150413.0,N,OT,AE,AE,2015,Q2,Adult
110210901,11021090,1,PS,Exenatide,EXENATIDE,1,Subcutaneous,"5 ?G, BID",,,,D,,,,5,UG,,Q12H,2015,Q2,Lactic acidosis,,2015,Q2,1,I,,20150330.0,20150413,20150413,EXP,,AE-SUN PHARMACEUTICAL INDUSTRIES LTD-2015R1-95580,RANBAXY,"AIJAZI I, ABDULLA FM, ZUBERI BJ, ELHASSAN A. EXENATIDE INDUCED ACUTE KIDNEY INJURY. J AYUB MED COLL. 2014;OCT;26(4):636?9",47.0,YR,,F,Y,,,20150413.0,N,OT,AE,AE,2015,Q2,Adult
110294271,11029427,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"10UG PEN, FREQUENCY UNKNOWN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Contusion,,2015,Q2,1,I,201409.0,20070722.0,20150415,20150415,PER,,US-ASTRAZENECA-2007BM12468,ASTRAZENECA,,46.0,YR,,M,Y,99.8,KG,20150415.0,N,CN,US,US,2015,Q2,Adult
110294271,11029427,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"10UG PEN, FREQUENCY UNKNOWN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Glycosylated haemoglobin increased,,2015,Q2,1,I,201409.0,20070722.0,20150415,20150415,PER,,US-ASTRAZENECA-2007BM12468,ASTRAZENECA,,46.0,YR,,M,Y,99.8,KG,20150415.0,N,CN,US,US,2015,Q2,Adult
110294271,11029427,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"10UG PEN, FREQUENCY UNKNOWN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Injection site pain,,2015,Q2,1,I,201409.0,20070722.0,20150415,20150415,PER,,US-ASTRAZENECA-2007BM12468,ASTRAZENECA,,46.0,YR,,M,Y,99.8,KG,20150415.0,N,CN,US,US,2015,Q2,Adult
110294271,11029427,4,SS,EXENATIDE,EXENATIDE,1,Unknown,"10UG PEN, FREQUENCY UNKNOWN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q2,Intentional product misuse,,2015,Q2,1,I,201409.0,20070722.0,20150415,20150415,PER,,US-ASTRAZENECA-2007BM12468,ASTRAZENECA,,46.0,YR,,M,Y,99.8,KG,20150415.0,N,CN,US,US,2015,Q2,Adult
110365591,11036559,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Dizziness,,2015,Q2,1,I,2007.0,20090218.0,20150416,20150416,PER,,US-ASTRAZENECA-2009BM02448,ASTRAZENECA,,59.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Adult
110365591,11036559,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Incorrect dose administered,,2015,Q2,1,I,2007.0,20090218.0,20150416,20150416,PER,,US-ASTRAZENECA-2009BM02448,ASTRAZENECA,,59.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Adult
110365591,11036559,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Injection site mass,,2015,Q2,1,I,2007.0,20090218.0,20150416,20150416,PER,,US-ASTRAZENECA-2009BM02448,ASTRAZENECA,,59.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Adult
110365591,11036559,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Nausea,,2015,Q2,1,I,2007.0,20090218.0,20150416,20150416,PER,,US-ASTRAZENECA-2009BM02448,ASTRAZENECA,,59.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Adult
110365591,11036559,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Tremor,,2015,Q2,1,I,2007.0,20090218.0,20150416,20150416,PER,,US-ASTRAZENECA-2009BM02448,ASTRAZENECA,,59.0,YR,,F,Y,,,20150416.0,N,CN,US,US,2015,Q2,Adult
110436251,11043625,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,5,UG,INJECTION,BID,2015,Q2,Cholangitis,,2015,Q2,1,I,,20150411.0,20150417,20150417,EXP,,FR-ASTRAZENECA-2015SE34438,ASTRAZENECA,,70.0,YR,,M,Y,,,20150417.0,N,OT,FR,FR,2015,Q2,Elderly
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Acute kidney injury,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Amylase increased,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Decreased appetite,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Dehydration,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Dialysis,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Drug intolerance,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Hypotension,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Lactic acidosis,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Nausea,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Tachycardia,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110542771,11054277,2,SS,EXENATIDE (EXENATIDE),EXENATIDE,1,Subcutaneous,,,,D,,,,,5,UG,,BID,2015,Q2,Vomiting,,2015,Q2,1,I,,20150406.0,20150420,20150420,EXP,,IPC201504-000208,IPCA,,47.0,YR,,F,N,,,20150417.0,N,OT,AE,,2015,Q2,Adult
110567892,11056789,8,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,2,UG,UNSPECIFIED,/wk,2015,Q2,Ketoacidosis,,2015,Q2,2,F,20141201.0,20150313.0,20150422,20150524,PER,,US-JNJFOC-20150311914,JANSSEN,,57.0,YR,A,M,Y,101.15,KG,20150524.0,N,MD,US,US,2015,Q2,Adult
110604741,11060474,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,22200.0,2,MG,INJECTION,/wk,2015,Q2,Drug dose omission,,2015,Q2,1,I,,20150107.0,20150423,20150423,PER,,US-ASTRAZENECA-2015SE06727,ASTRAZENECA,,58.0,YR,,M,Y,98.9,KG,20150423.0,N,CN,US,US,2015,Q2,Adult
110604741,11060474,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,22200.0,2,MG,INJECTION,/wk,2015,Q2,Weight decreased,,2015,Q2,1,I,,20150107.0,20150423,20150423,PER,,US-ASTRAZENECA-2015SE06727,ASTRAZENECA,,58.0,YR,,M,Y,98.9,KG,20150423.0,N,CN,US,US,2015,Q2,Adult
110916461,11091646,5,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Back pain,,2015,Q2,1,I,200903.0,20090730.0,20150505,20150505,PER,,US-ASTRAZENECA-2009BM09186,ASTRAZENECA,,753.0,MON,,F,Y,83.9,KG,20150505.0,N,,US,US,2015,Q2,Elderly
110916461,11091646,5,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Diarrhoea,,2015,Q2,1,I,200903.0,20090730.0,20150505,20150505,PER,,US-ASTRAZENECA-2009BM09186,ASTRAZENECA,,753.0,MON,,F,Y,83.9,KG,20150505.0,N,,US,US,2015,Q2,Elderly
110916461,11091646,5,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Injection site pain,,2015,Q2,1,I,200903.0,20090730.0,20150505,20150505,PER,,US-ASTRAZENECA-2009BM09186,ASTRAZENECA,,753.0,MON,,F,Y,83.9,KG,20150505.0,N,,US,US,2015,Q2,Elderly
110916461,11091646,5,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Nausea,,2015,Q2,1,I,200903.0,20090730.0,20150505,20150505,PER,,US-ASTRAZENECA-2009BM09186,ASTRAZENECA,,753.0,MON,,F,Y,83.9,KG,20150505.0,N,,US,US,2015,Q2,Elderly
110938511,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Disturbance in attention,,2015,Q2,1,I,200506.0,20070816.0,20150506,20150506,PER,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,53.0,YR,,M,Y,156.5,KG,20150506.0,N,CN,US,US,2015,Q2,Adult
110938511,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Dizziness,,2015,Q2,1,I,200506.0,20070816.0,20150506,20150506,PER,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,53.0,YR,,M,Y,156.5,KG,20150506.0,N,CN,US,US,2015,Q2,Adult
110938511,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Feeling abnormal,,2015,Q2,1,I,200506.0,20070816.0,20150506,20150506,PER,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,53.0,YR,,M,Y,156.5,KG,20150506.0,N,CN,US,US,2015,Q2,Adult
110938511,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Influenza like illness,,2015,Q2,1,I,200506.0,20070816.0,20150506,20150506,PER,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,53.0,YR,,M,Y,156.5,KG,20150506.0,N,CN,US,US,2015,Q2,Adult
110938511,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Nausea,,2015,Q2,1,I,200506.0,20070816.0,20150506,20150506,PER,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,53.0,YR,,M,Y,156.5,KG,20150506.0,N,CN,US,US,2015,Q2,Adult
110938511,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Weight decreased,,2015,Q2,1,I,200506.0,20070816.0,20150506,20150506,PER,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,53.0,YR,,M,Y,156.5,KG,20150506.0,N,CN,US,US,2015,Q2,Adult
111274431,11127443,1,PS,EXENATIDE,EXENATIDE,1,,,,,Y,D,,,,2,MG,,QW,2015,Q2,Injection site bruising,,2015,Q2,1,I,20150507.0,,20150520,20150520,DIR,,,,,58.0,YR,,F,N,81.8,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111274431,11127443,1,PS,EXENATIDE,EXENATIDE,1,,,,,Y,D,,,,2,MG,,QW,2015,Q2,Injection site induration,,2015,Q2,1,I,20150507.0,,20150520,20150520,DIR,,,,,58.0,YR,,F,N,81.8,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111274431,11127443,1,PS,EXENATIDE,EXENATIDE,1,,,,,Y,D,,,,2,MG,,QW,2015,Q2,Injection site nodule,,2015,Q2,1,I,20150507.0,,20150520,20150520,DIR,,,,,58.0,YR,,F,N,81.8,KG,20150519.0,N,PH,US,,2015,Q2,Adult
111437111,11143711,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q2,Diabetes mellitus inadequate control,,2015,Q2,1,I,20080715.0,20080722.0,20150526,20150526,PER,,US-ASTRAZENECA-2014SE32651,ASTRAZENECA,,61.0,YR,,F,Y,87.5,KG,20150526.0,N,CN,US,US,2015,Q2,Adult
111437111,11143711,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q2,Diarrhoea,,2015,Q2,1,I,20080715.0,20080722.0,20150526,20150526,PER,,US-ASTRAZENECA-2014SE32651,ASTRAZENECA,,61.0,YR,,F,Y,87.5,KG,20150526.0,N,CN,US,US,2015,Q2,Adult
111437111,11143711,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q2,Injection site nodule,,2015,Q2,1,I,20080715.0,20080722.0,20150526,20150526,PER,,US-ASTRAZENECA-2014SE32651,ASTRAZENECA,,61.0,YR,,F,Y,87.5,KG,20150526.0,N,CN,US,US,2015,Q2,Adult
111437111,11143711,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q2,Injection site pain,,2015,Q2,1,I,20080715.0,20080722.0,20150526,20150526,PER,,US-ASTRAZENECA-2014SE32651,ASTRAZENECA,,61.0,YR,,F,Y,87.5,KG,20150526.0,N,CN,US,US,2015,Q2,Adult
111437111,11143711,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q2,Retching,,2015,Q2,1,I,20080715.0,20080722.0,20150526,20150526,PER,,US-ASTRAZENECA-2014SE32651,ASTRAZENECA,,61.0,YR,,F,Y,87.5,KG,20150526.0,N,CN,US,US,2015,Q2,Adult
111457221,11145722,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,5 MCG  BID  SQ,,,N,D,,,,5,UG,,BID,2015,Q2,Rash pruritic,,2015,Q2,1,I,20150215.0,,20150527,20150527,DIR,,,,,67.0,YR,,M,N,124.1,KG,20150526.0,N,PH,US,,2015,Q2,Elderly
111457221,11145722,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,5 MCG  BID  SQ,,,N,D,,,,5,UG,,BID,2015,Q2,Urticaria,,2015,Q2,1,I,20150215.0,,20150527,20150527,DIR,,,,,67.0,YR,,M,N,124.1,KG,20150526.0,N,PH,US,,2015,Q2,Elderly
111498771,11149877,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,/wk,2015,Q2,Cerebral haemorrhage,,2015,Q2,1,I,20150514.0,20150527.0,20150529,20150529,EXP,,ES-ABBVIE-15P-144-1398489-00,ABBVIE,,56.0,YR,,M,Y,,,20150529.0,N,MD,ES,ES,2015,Q2,Adult
111986941,11198694,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q2,Muscular weakness,,2015,Q2,1,I,,20150324.0,20150608,20150608,PER,,2015TUS003870,TAKEDA,,50.0,YR,,M,N,,,20150421.0,N,OT,US,,2015,Q2,Adult
111986941,11198694,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q2,Musculoskeletal pain,,2015,Q2,1,I,,20150324.0,20150608,20150608,PER,,2015TUS003870,TAKEDA,,50.0,YR,,M,N,,,20150421.0,N,OT,US,,2015,Q2,Adult
111986941,11198694,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q2,Pain in extremity,,2015,Q2,1,I,,20150324.0,20150608,20150608,PER,,2015TUS003870,TAKEDA,,50.0,YR,,M,N,,,20150421.0,N,OT,US,,2015,Q2,Adult
111986941,11198694,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q2,Peripheral swelling,,2015,Q2,1,I,,20150324.0,20150608,20150608,PER,,2015TUS003870,TAKEDA,,50.0,YR,,M,N,,,20150421.0,N,OT,US,,2015,Q2,Adult
112024501,11202450,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,1/WEEK,,,,D,,,,,,INJECTION,,2015,Q2,Pancreatitis,,2015,Q2,1,I,20150527.0,20150611.0,20150619,20150619,EXP,,DE-ASTRAZENECA-2015SE58974,ASTRAZENECA,,74.0,YR,,M,Y,99.0,KG,20150619.0,N,MD,DE,DE,2015,Q2,Elderly
112173891,11217389,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Abdominal distension,,2015,Q2,1,I,200805.0,20080617.0,20150625,20150625,PER,,US-ASTRAZENECA-2008BM08521,ASTRAZENECA,,54.0,YR,,F,Y,101.6,KG,20150625.0,N,CN,US,US,2015,Q2,Adult
112173891,11217389,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Decreased appetite,,2015,Q2,1,I,200805.0,20080617.0,20150625,20150625,PER,,US-ASTRAZENECA-2008BM08521,ASTRAZENECA,,54.0,YR,,F,Y,101.6,KG,20150625.0,N,CN,US,US,2015,Q2,Adult
112173891,11217389,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Diarrhoea,,2015,Q2,1,I,200805.0,20080617.0,20150625,20150625,PER,,US-ASTRAZENECA-2008BM08521,ASTRAZENECA,,54.0,YR,,F,Y,101.6,KG,20150625.0,N,CN,US,US,2015,Q2,Adult
112173891,11217389,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Feeling abnormal,,2015,Q2,1,I,200805.0,20080617.0,20150625,20150625,PER,,US-ASTRAZENECA-2008BM08521,ASTRAZENECA,,54.0,YR,,F,Y,101.6,KG,20150625.0,N,CN,US,US,2015,Q2,Adult
112173891,11217389,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Feeling cold,,2015,Q2,1,I,200805.0,20080617.0,20150625,20150625,PER,,US-ASTRAZENECA-2008BM08521,ASTRAZENECA,,54.0,YR,,F,Y,101.6,KG,20150625.0,N,CN,US,US,2015,Q2,Adult
112173891,11217389,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Nausea,,2015,Q2,1,I,200805.0,20080617.0,20150625,20150625,PER,,US-ASTRAZENECA-2008BM08521,ASTRAZENECA,,54.0,YR,,F,Y,101.6,KG,20150625.0,N,CN,US,US,2015,Q2,Adult
112173891,11217389,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Weight decreased,,2015,Q2,1,I,200805.0,20080617.0,20150625,20150625,PER,,US-ASTRAZENECA-2008BM08521,ASTRAZENECA,,54.0,YR,,F,Y,101.6,KG,20150625.0,N,CN,US,US,2015,Q2,Adult
112174001,11217400,7,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Cough,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112174001,11217400,7,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Dizziness,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112174001,11217400,7,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Sneezing,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112174001,11217400,7,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Visual impairment,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112174001,11217400,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10,UG,SOLUTION FOR INJECTION,,2015,Q2,Cough,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112174001,11217400,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10,UG,SOLUTION FOR INJECTION,,2015,Q2,Dizziness,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112174001,11217400,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10,UG,SOLUTION FOR INJECTION,,2015,Q2,Sneezing,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112174001,11217400,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10,UG,SOLUTION FOR INJECTION,,2015,Q2,Visual impairment,,2015,Q2,1,I,2010.0,20100519.0,20150625,20150625,PER,,US-ASTRAZENECA-2010BM06541,ASTRAZENECA,,56.0,YR,,F,Y,142.9,KG,20150625.0,N,,US,US,2015,Q2,Adult
112231681,11223168,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,21773.0,,,INJECTION,,2015,Q2,Abdominal pain,,2015,Q2,1,I,20150522.0,20150619.0,20150626,20150626,EXP,,GB-ASTRAZENECA-2015SE61342,ASTRAZENECA,,58.0,YR,,M,Y,82.0,KG,20150626.0,N,MD,GB,GB,2015,Q2,Adult
112231681,11223168,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,21773.0,,,INJECTION,,2015,Q2,Amylase increased,,2015,Q2,1,I,20150522.0,20150619.0,20150626,20150626,EXP,,GB-ASTRAZENECA-2015SE61342,ASTRAZENECA,,58.0,YR,,M,Y,82.0,KG,20150626.0,N,MD,GB,GB,2015,Q2,Adult
112231681,11223168,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,21773.0,,,INJECTION,,2015,Q2,Pancreatitis acute,,2015,Q2,1,I,20150522.0,20150619.0,20150626,20150626,EXP,,GB-ASTRAZENECA-2015SE61342,ASTRAZENECA,,58.0,YR,,M,Y,82.0,KG,20150626.0,N,MD,GB,GB,2015,Q2,Adult
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Blood glucose decreased,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Decreased appetite,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Dizziness,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Headache,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Injury associated with device,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Product quality issue,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Underdose,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
112239431,11223943,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q2,Weight decreased,,2015,Q2,1,I,201107.0,20110822.0,20150629,20150629,PER,,US-ASTRAZENECA-2011BM10101,ASTRAZENECA,,69.0,YR,,M,Y,83.9,KG,20150629.0,N,,US,US,2015,Q2,Elderly
108721524,10872152,18,C,EXENATIDE MICROSPHERES,,2,Oral,,,,,D,,,,,,,,2015,Q3,Non-cardiac chest pain,Non-cardiac chest pain,2015,Q3,4,F,20150103.0,20150807.0,20150226,20150812,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-003422,EISAI,,57.0,YR,,M,Y,128.8,KG,20150812.0,N,MD,US,US,2015,Q3,Adult
108721524,10872152,18,C,EXENATIDE MICROSPHERES,,2,Oral,,,,,D,,,,,,,,2015,Q3,Upper respiratory tract infection,,2015,Q3,4,F,20150103.0,20150807.0,20150226,20150812,PER,,US-EISAI MEDICAL RESEARCH-EC-2015-003422,EISAI,,57.0,YR,,M,Y,128.8,KG,20150812.0,N,MD,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Abdominal distension,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Blood glucose abnormal,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Blood glucose decreased,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Drug effect decreased,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Intentional device misuse,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Intentional product misuse,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Product quality issue,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109203082,10920308,3,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Weight decreased,,2015,Q3,2,F,200704.0,20150713.0,20150317,20150724,PER,,US-ASTRAZENECA-2007BM11163,ASTRAZENECA,,62.0,YR,,F,Y,120.6,KG,20150724.0,N,,US,US,2015,Q3,Adult
109939522,10993952,5,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q3,Incorrect dose administered,,2015,Q3,2,F,2007.0,20150810.0,20150407,20150824,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,56.0,YR,,F,Y,81.2,KG,20150824.0,N,,US,US,2015,Q3,Adult
109939522,10993952,5,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q3,Increased appetite,,2015,Q3,2,F,2007.0,20150810.0,20150407,20150824,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,56.0,YR,,F,Y,81.2,KG,20150824.0,N,,US,US,2015,Q3,Adult
109939522,10993952,5,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q3,Injection site mass,,2015,Q3,2,F,2007.0,20150810.0,20150407,20150824,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,56.0,YR,,F,Y,81.2,KG,20150824.0,N,,US,US,2015,Q3,Adult
109939522,10993952,5,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q3,Injection site nodule,,2015,Q3,2,F,2007.0,20150810.0,20150407,20150824,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,56.0,YR,,F,Y,81.2,KG,20150824.0,N,,US,US,2015,Q3,Adult
109939522,10993952,5,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q3,Injection site pain,,2015,Q3,2,F,2007.0,20150810.0,20150407,20150824,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,56.0,YR,,F,Y,81.2,KG,20150824.0,N,,US,US,2015,Q3,Adult
109939522,10993952,5,C,"EXENATIDE PEN, DISPOSABLE DEVICE",EXENATIDE,1,Unknown,10MCG,,,,D,,,,,,INJECTION,,2015,Q3,Product quality issue,,2015,Q3,2,F,2007.0,20150810.0,20150407,20150824,PER,,US-ASTRAZENECA-2007BM15434,ASTRAZENECA,,56.0,YR,,F,Y,81.2,KG,20150824.0,N,,US,US,2015,Q3,Adult
110061732,11006173,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,2,MG,INJECTION,/wk,2015,Q3,Pancreatitis,,2015,Q3,2,F,20130722.0,20150911.0,20150409,20150917,EXP,,US-ASTRAZENECA-2013SE64092,ASTRAZENECA,,61.0,YR,,M,Y,111.6,KG,20150917.0,N,CN,US,US,2015,Q3,Adult
111977032,11197703,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,ONCE WEEKLY,,,,D,,,,,,INJECTION,,2015,Q3,Thyroid cancer,,2015,Q3,2,F,20150323.0,20150717.0,20150617,20150724,EXP,,US-ASTRAZENECA-2015SE50933,ASTRAZENECA,,21886.0,DY,,M,Y,110.7,KG,20150724.0,N,MD,US,US,2015,Q3,Elderly
112356351,11235635,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,21773.0,,,,,2015,Q3,Asthma,,2015,Q3,1,I,20150526.0,20150624.0,20150702,20150702,EXP,,GB-ASTRAZENECA-2015SE62596,ASTRAZENECA,,71.0,YR,,F,Y,134.0,KG,20150702.0,N,MD,GB,GB,2015,Q3,Elderly
112356351,11235635,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,21773.0,,,,,2015,Q3,Lip swelling,,2015,Q3,1,I,20150526.0,20150624.0,20150702,20150702,EXP,,GB-ASTRAZENECA-2015SE62596,ASTRAZENECA,,71.0,YR,,F,Y,134.0,KG,20150702.0,N,MD,GB,GB,2015,Q3,Elderly
112356351,11235635,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,21773.0,,,,,2015,Q3,Urticaria,,2015,Q3,1,I,20150526.0,20150624.0,20150702,20150702,EXP,,GB-ASTRAZENECA-2015SE62596,ASTRAZENECA,,71.0,YR,,F,Y,134.0,KG,20150702.0,N,MD,GB,GB,2015,Q3,Elderly
112365821,11236582,4,C,EXENATIDE,EXENATIDE,1,Subcutaneous,UNK,,,,U,,,,,,,,2015,Q3,Seizure,,2015,Q3,1,I,,20150409.0,20150702,20150702,PER,,US-TAKEDA-2015TUS004707,TAKEDA,,54.0,YR,,F,Y,,,20150703.0,N,CN,US,US,2015,Q3,Adult
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Aortic aneurysm,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Atrial fibrillation,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Drug intolerance,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Epistaxis,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Hunger,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injection site haemorrhage,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Intentional product misuse,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Loss of consciousness,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Malaise,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Mouth haemorrhage,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Nausea,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Off label use,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Vomiting,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112383151,11238315,8,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,200905.0,20100614.0,20150704,20150704,EXP,,US-ASTRAZENECA-2010BM07206,ASTRAZENECA,,848.0,MON,,F,Y,113.4,KG,20150704.0,N,,US,US,2015,Q3,Elderly
112505281,11250528,5,C,EXENATIDE,EXENATIDE,1,,USE AS DIRECTED.,,,,D,,,,,,,,2015,Q3,Sudden hearing loss,,2015,Q3,1,I,20150531.0,20150703.0,20150708,20150708,EXP,GB-MHRA-TPP31676598C2152986YC1434703790399,GB-TEVA-575778ACC,TEVA,,53.0,YR,,F,Y,102.0,KG,20150708.0,N,MD,GB,GB,2015,Q3,Adult
112505661,11250566,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,2010.0,20100303.0,20150708,20150708,PER,,US-ASTRAZENECA-2010BM03712,ASTRAZENECA,,69.0,YR,,F,Y,79.4,KG,20150708.0,N,CN,US,US,2015,Q3,Elderly
112505661,11250566,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,2010.0,20100303.0,20150708,20150708,PER,,US-ASTRAZENECA-2010BM03712,ASTRAZENECA,,69.0,YR,,F,Y,79.4,KG,20150708.0,N,CN,US,US,2015,Q3,Elderly
112505661,11250566,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Incorrect dose administered,,2015,Q3,1,I,2010.0,20100303.0,20150708,20150708,PER,,US-ASTRAZENECA-2010BM03712,ASTRAZENECA,,69.0,YR,,F,Y,79.4,KG,20150708.0,N,CN,US,US,2015,Q3,Elderly
112505661,11250566,4,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injection site pain,,2015,Q3,1,I,2010.0,20100303.0,20150708,20150708,PER,,US-ASTRAZENECA-2010BM03712,ASTRAZENECA,,69.0,YR,,F,Y,79.4,KG,20150708.0,N,CN,US,US,2015,Q3,Elderly
112579671,11257967,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Asthenia,,2015,Q3,1,I,200705.0,20070521.0,20150710,20150710,PER,,US-ASTRAZENECA-2007BM08080,ASTRAZENECA,,66.0,YR,,M,Y,79.4,KG,20150710.0,N,,US,US,2015,Q3,Elderly
112579671,11257967,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Circumstance or information capable of leading to medication error,,2015,Q3,1,I,200705.0,20070521.0,20150710,20150710,PER,,US-ASTRAZENECA-2007BM08080,ASTRAZENECA,,66.0,YR,,M,Y,79.4,KG,20150710.0,N,,US,US,2015,Q3,Elderly
112579671,11257967,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Intentional device misuse,,2015,Q3,1,I,200705.0,20070521.0,20150710,20150710,PER,,US-ASTRAZENECA-2007BM08080,ASTRAZENECA,,66.0,YR,,M,Y,79.4,KG,20150710.0,N,,US,US,2015,Q3,Elderly
112579671,11257967,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Nausea,,2015,Q3,1,I,200705.0,20070521.0,20150710,20150710,PER,,US-ASTRAZENECA-2007BM08080,ASTRAZENECA,,66.0,YR,,M,Y,79.4,KG,20150710.0,N,,US,US,2015,Q3,Elderly
112922171,11292217,7,C,EXENATIDE,EXENATIDE,1,,20 MICROGRAM DAILY;,420.0,UG,,D,,,,10,UG,,BID,2015,Q3,Contusion,,2015,Q3,1,I,20150706.0,20150715.0,20150722,20150722,EXP,GB-MHRA-TPP13529983C648030YC1436179319502,GB-TEVA-578854ACC,TEVA,,74.0,YR,,F,Y,88.0,KG,20150722.0,N,MD,GB,GB,2015,Q3,Elderly
112922171,11292217,7,C,EXENATIDE,EXENATIDE,1,,20 MICROGRAM DAILY;,420.0,UG,,D,,,,10,UG,,BID,2015,Q3,Rash,,2015,Q3,1,I,20150706.0,20150715.0,20150722,20150722,EXP,GB-MHRA-TPP13529983C648030YC1436179319502,GB-TEVA-578854ACC,TEVA,,74.0,YR,,F,Y,88.0,KG,20150722.0,N,MD,GB,GB,2015,Q3,Elderly
112954521,11295452,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,Y,D,,,,10.0,UG,,BID,2015,Q3,Acute kidney injury,,2015,Q3,1,I,20101102.0,,20150722,20150722,DIR,,,,,66.0,YR,,M,N,,,20110104.0,N,PH,US,,2015,Q3,Elderly
112954521,11295452,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,Y,D,,,,10.0,UG,,BID,2015,Q3,Hepatic enzyme increased,,2015,Q3,1,I,20101102.0,,20150722,20150722,DIR,,,,,66.0,YR,,M,N,,,20110104.0,N,PH,US,,2015,Q3,Elderly
112954521,11295452,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,Y,D,,,,10.0,UG,,BID,2015,Q3,Pancreatitis,,2015,Q3,1,I,20101102.0,,20150722,20150722,DIR,,,,,66.0,YR,,M,N,,,20110104.0,N,PH,US,,2015,Q3,Elderly
112954521,11295452,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,Y,D,,,,10.0,UG,,BID,2015,Q3,Polydipsia,,2015,Q3,1,I,20101102.0,,20150722,20150722,DIR,,,,,66.0,YR,,M,N,,,20110104.0,N,PH,US,,2015,Q3,Elderly
112954521,11295452,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,Y,D,,,,10.0,UG,,BID,2015,Q3,Polyuria,,2015,Q3,1,I,20101102.0,,20150722,20150722,DIR,,,,,66.0,YR,,M,N,,,20110104.0,N,PH,US,,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Dizziness,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Eczema,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Feeling abnormal,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Glycosylated haemoglobin increased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Injection site nodule,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Injection site pain,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Product quality issue,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,4,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,5.0,UG,INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Dizziness,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Eczema,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Feeling abnormal,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Glycosylated haemoglobin increased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injection site nodule,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injection site pain,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Product quality issue,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113031001,11303100,5,C,"EXENATIDE 10mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,2009.0,20110308.0,20150723,20150723,PER,,US-ASTRAZENECA-2011BM05855,ASTRAZENECA,,69.0,YR,,F,Y,65.8,KG,20150723.0,N,CN,US,US,2015,Q3,Elderly
113064541,11306454,6,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN,",,,,D,,,,,,INJECTION,,2015,Q3,Early satiety,,2015,Q3,1,I,2006.0,20080612.0,20150723,20150723,EXP,,US-ASTRAZENECA-2008BM08357,ASTRAZENECA,,66.0,YR,,F,Y,91.6,KG,20150723.0,N,,US,US,2015,Q3,Elderly
113064541,11306454,6,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN,",,,,D,,,,,,INJECTION,,2015,Q3,Intentional product misuse,,2015,Q3,1,I,2006.0,20080612.0,20150723,20150723,EXP,,US-ASTRAZENECA-2008BM08357,ASTRAZENECA,,66.0,YR,,F,Y,91.6,KG,20150723.0,N,,US,US,2015,Q3,Elderly
113064541,11306454,6,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN,",,,,D,,,,,,INJECTION,,2015,Q3,Metastatic uterine cancer,,2015,Q3,1,I,2006.0,20080612.0,20150723,20150723,EXP,,US-ASTRAZENECA-2008BM08357,ASTRAZENECA,,66.0,YR,,F,Y,91.6,KG,20150723.0,N,,US,US,2015,Q3,Elderly
113064541,11306454,6,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN,",,,,D,,,,,,INJECTION,,2015,Q3,Nausea,,2015,Q3,1,I,2006.0,20080612.0,20150723,20150723,EXP,,US-ASTRAZENECA-2008BM08357,ASTRAZENECA,,66.0,YR,,F,Y,91.6,KG,20150723.0,N,,US,US,2015,Q3,Elderly
113064541,11306454,6,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN,",,,,D,,,,,,INJECTION,,2015,Q3,Product quality issue,,2015,Q3,1,I,2006.0,20080612.0,20150723,20150723,EXP,,US-ASTRAZENECA-2008BM08357,ASTRAZENECA,,66.0,YR,,F,Y,91.6,KG,20150723.0,N,,US,US,2015,Q3,Elderly
113064541,11306454,6,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN,",,,,D,,,,,,INJECTION,,2015,Q3,Underdose,,2015,Q3,1,I,2006.0,20080612.0,20150723,20150723,EXP,,US-ASTRAZENECA-2008BM08357,ASTRAZENECA,,66.0,YR,,F,Y,91.6,KG,20150723.0,N,,US,US,2015,Q3,Elderly
113064541,11306454,6,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN,",,,,D,,,,,,INJECTION,,2015,Q3,Vaginal haemorrhage,,2015,Q3,1,I,2006.0,20080612.0,20150723,20150723,EXP,,US-ASTRAZENECA-2008BM08357,ASTRAZENECA,,66.0,YR,,F,Y,91.6,KG,20150723.0,N,,US,US,2015,Q3,Elderly
113092581,11309258,7,C,EXENATIDE,EXENATIDE,1,Unknown,"10 UG, BID",420.0,UG,,D,,,,10.0,UG,,BID,2015,Q3,Contusion,,2015,Q3,1,I,20150706.0,20150715.0,20150724,20150724,EXP,GB-MHRA-TPP13529983C648030YC1436179319502,PHHY2015GB085080,SANDOZ,,74.0,YR,,F,Y,88.0,KG,20150724.0,N,OT,GB,GB,2015,Q3,Elderly
113092581,11309258,7,C,EXENATIDE,EXENATIDE,1,Unknown,"10 UG, BID",420.0,UG,,D,,,,10.0,UG,,BID,2015,Q3,Rash,,2015,Q3,1,I,20150706.0,20150715.0,20150724,20150724,EXP,GB-MHRA-TPP13529983C648030YC1436179319502,PHHY2015GB085080,SANDOZ,,74.0,YR,,F,Y,88.0,KG,20150724.0,N,OT,GB,GB,2015,Q3,Elderly
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute kidney injury,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute lung injury,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Cardiopulmonary failure,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Distributive shock,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Encephalopathy,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Fluid overload,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Hypoglycaemia,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Intentional overdose,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Lactic acidosis,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Metabolic acidosis,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Pulmonary hypertension,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154622,11315462,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Right ventricular dysfunction,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-ALKEM-001098,ALKEM,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154741,11315474,7,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, TWO TIMES A DAY",420.0,UG,,U,,,,10.0,UG,,BID,2015,Q3,Contusion,,2015,Q3,1,I,20150706.0,20150715.0,20150728,20150728,EXP,,GB-AUROBINDO-AUR-APL-2015-06603,AUROBINDO,,74.0,YR,,F,Y,88.0,KG,20150728.0,N,MD,GB,GB,2015,Q3,Elderly
113154741,11315474,7,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, TWO TIMES A DAY",420.0,UG,,U,,,,10.0,UG,,BID,2015,Q3,Rash,,2015,Q3,1,I,20150706.0,20150715.0,20150728,20150728,EXP,,GB-AUROBINDO-AUR-APL-2015-06603,AUROBINDO,,74.0,YR,,F,Y,88.0,KG,20150728.0,N,MD,GB,GB,2015,Q3,Elderly
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute kidney injury,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute lung injury,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Cardiopulmonary failure,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Distributive shock,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Encephalopathy,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Fluid overload,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Hypoglycaemia,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Intentional overdose,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Lactic acidosis,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Metabolic acidosis,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Pulmonary hypertension,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113154832,11315483,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Right ventricular dysfunction,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INVENTIA-000063,INVENTIA HEALTHCARE,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute kidney injury,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute lung injury,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Cardiopulmonary failure,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Distributive shock,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Encephalopathy,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Fluid overload,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Hypoglycaemia,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Intentional overdose,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Lactic acidosis,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Metabolic acidosis,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Pulmonary hypertension,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113155192,11315519,2,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Right ventricular dysfunction,,2015,Q3,2,F,,20150824.0,20150728,20150903,EXP,,AU-INDICUS PHARMA-000347,INDICUS,"GRAHAM RE, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015 JUL 6; 2015.",44.0,YR,,M,Y,,,20150903.0,N,MD,AU,AU,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Abdominal pain,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Acute lung injury,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Acute respiratory distress syndrome,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Anion gap increased,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Ejection fraction decreased,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Encephalopathy,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Fluid overload,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Haemodialysis,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Intentional overdose,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Lactic acidosis,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Legal problem,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Lung infiltration,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Metabolic acidosis,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Respiratory failure,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Respiratory gas exchange disorder,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Right ventricular dysfunction,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Shock,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Tachyarrhythmia,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Vasoplegia syndrome,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113167641,11316764,4,C,EXENATIDE (EXENATIDE),EXENATIDE,1,,,,,,,,,,,,,,2015,Q3,Vomiting,,2015,Q3,1,I,,20150713.0,20150724,20150724,EXP,,IPC201507-000465,IPCA,,44.0,YR,,M,N,,,20150723.0,N,OT,AU,,2015,Q3,Adult
113168001,11316800,9,C,EXENATIDE (EXENATIDE) (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Contusion,,2015,Q3,1,I,20150706.0,20150715.0,20150724,20150724,EXP,,GB-H14001-15-01362,WESTWARD,,74.0,YR,,F,N,,,20150723.0,N,MD,GB,,2015,Q3,Elderly
113168001,11316800,9,C,EXENATIDE (EXENATIDE) (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Rash,,2015,Q3,1,I,20150706.0,20150715.0,20150724,20150724,EXP,,GB-H14001-15-01362,WESTWARD,,74.0,YR,,F,N,,,20150723.0,N,MD,GB,,2015,Q3,Elderly
113185471,11318547,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Drug ineffective,,2015,Q3,1,I,20090501.0,20090504.0,20150729,20150729,PER,,US-ASTRAZENECA-2009BM05630,ASTRAZENECA,,16028.0,DY,,F,Y,70.3,KG,20150729.0,N,CN,US,US,2015,Q3,Elderly
113185471,11318547,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injection site pain,,2015,Q3,1,I,20090501.0,20090504.0,20150729,20150729,PER,,US-ASTRAZENECA-2009BM05630,ASTRAZENECA,,16028.0,DY,,F,Y,70.3,KG,20150729.0,N,CN,US,US,2015,Q3,Elderly
113185471,11318547,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Muscle spasms,,2015,Q3,1,I,20090501.0,20090504.0,20150729,20150729,PER,,US-ASTRAZENECA-2009BM05630,ASTRAZENECA,,16028.0,DY,,F,Y,70.3,KG,20150729.0,N,CN,US,US,2015,Q3,Elderly
113217531,11321753,8,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,20.0,UG,,QD,2015,Q3,Urosepsis,,2015,Q3,1,I,20141203.0,20141216.0,20150729,20150729,EXP,,US-ASTRAZENECA-2015SE00319,ASTRAZENECA,,71.0,YR,,M,Y,,,20150729.0,N,CN,US,US,2015,Q3,Elderly
113264922,11326492,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Breast enlargement,,2015,Q3,2,F,200802.0,20150721.0,20150731,20150805,PER,,US-ASTRAZENECA-2008BM10831,ASTRAZENECA,,56.0,YR,,M,Y,136.0,KG,20150805.0,N,CN,US,US,2015,Q3,Adult
113264922,11326492,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Decreased appetite,,2015,Q3,2,F,200802.0,20150721.0,20150731,20150805,PER,,US-ASTRAZENECA-2008BM10831,ASTRAZENECA,,56.0,YR,,M,Y,136.0,KG,20150805.0,N,CN,US,US,2015,Q3,Adult
113264922,11326492,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Diarrhoea,,2015,Q3,2,F,200802.0,20150721.0,20150731,20150805,PER,,US-ASTRAZENECA-2008BM10831,ASTRAZENECA,,56.0,YR,,M,Y,136.0,KG,20150805.0,N,CN,US,US,2015,Q3,Adult
113264922,11326492,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Drug ineffective,,2015,Q3,2,F,200802.0,20150721.0,20150731,20150805,PER,,US-ASTRAZENECA-2008BM10831,ASTRAZENECA,,56.0,YR,,M,Y,136.0,KG,20150805.0,N,CN,US,US,2015,Q3,Adult
113288121,11328812,10,C,EXENATIDE,EXENATIDE,1,,UNK,,,,U,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150731,20150731,EXP,GB-MHRA-EYC 00126015,GB-009507513-1507GBR013976,MERCK,,63.0,YR,,M,Y,,,20150731.0,N,PH,GB,GB,2015,Q3,Adult
113288121,11328812,10,C,EXENATIDE,EXENATIDE,1,,UNK,,,,U,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150731,20150731,EXP,GB-MHRA-EYC 00126015,GB-009507513-1507GBR013976,MERCK,,63.0,YR,,M,Y,,,20150731.0,N,PH,GB,GB,2015,Q3,Adult
113291371,11329137,10,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150803,20150803,EXP,GB-MHRA-EYC 00126015,GB-MICRO LABS LIMITED-BB2015-00833,MICRO LABS,,63.0,YR,,M,Y,,,20150803.0,N,OT,GB,GB,2015,Q3,Adult
113291371,11329137,10,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150803,20150803,EXP,GB-MHRA-EYC 00126015,GB-MICRO LABS LIMITED-BB2015-00833,MICRO LABS,,63.0,YR,,M,Y,,,20150803.0,N,OT,GB,GB,2015,Q3,Adult
113312362,11331236,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,2,F,20131130.0,20140219.0,20150803,20150907,EXP,,US-ASTRAZENECA-2014SE09550,ASTRAZENECA,,73.0,YR,,M,Y,109.8,KG,20150907.0,N,CN,US,US,2015,Q3,Elderly
113312362,11331236,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Drug ineffective,,2015,Q3,2,F,20131130.0,20140219.0,20150803,20150907,EXP,,US-ASTRAZENECA-2014SE09550,ASTRAZENECA,,73.0,YR,,M,Y,109.8,KG,20150907.0,N,CN,US,US,2015,Q3,Elderly
113312362,11331236,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Product quality issue,,2015,Q3,2,F,20131130.0,20140219.0,20150803,20150907,EXP,,US-ASTRAZENECA-2014SE09550,ASTRAZENECA,,73.0,YR,,M,Y,109.8,KG,20150907.0,N,CN,US,US,2015,Q3,Elderly
113312362,11331236,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Renal disorder,,2015,Q3,2,F,20131130.0,20140219.0,20150803,20150907,EXP,,US-ASTRAZENECA-2014SE09550,ASTRAZENECA,,73.0,YR,,M,Y,109.8,KG,20150907.0,N,CN,US,US,2015,Q3,Elderly
113312362,11331236,4,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Weight decreased,,2015,Q3,2,F,20131130.0,20140219.0,20150803,20150907,EXP,,US-ASTRAZENECA-2014SE09550,ASTRAZENECA,,73.0,YR,,M,Y,109.8,KG,20150907.0,N,CN,US,US,2015,Q3,Elderly
113354811,11335481,20,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150804,20150804,EXP,,GB-JNJFOC-20150721828,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,,,20150804.0,N,PH,GB,GB,2015,Q3,Adult
113354811,11335481,20,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,UNSPECIFIED,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150804,20150804,EXP,,GB-JNJFOC-20150721828,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,,,20150804.0,N,PH,GB,GB,2015,Q3,Adult
113400741,11340074,11,C,EXENATIDE,EXENATIDE,1,Unknown,"UNKNOWN, UNKNOWN",,,,D, UNKNOWN,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150805,20150805,EXP,,GB-PERRIGO-15GB007779,PERRIGO,,63.0,YR,,M,Y,,,20150805.0,N,PH,GB,GB,2015,Q3,Adult
113400741,11340074,11,C,EXENATIDE,EXENATIDE,1,Unknown,"UNKNOWN, UNKNOWN",,,,D, UNKNOWN,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150805,20150805,EXP,,GB-PERRIGO-15GB007779,PERRIGO,,63.0,YR,,M,Y,,,20150805.0,N,PH,GB,GB,2015,Q3,Adult
113405761,11340576,10,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150805,20150805,EXP,GB-MHRA-EYC 00126015,GB-PFIZER INC-2015254730,PFIZER,,63.0,YR,,M,Y,,,20150805.0,N,PH,GB,GB,2015,Q3,Adult
113405761,11340576,10,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150805,20150805,EXP,GB-MHRA-EYC 00126015,GB-PFIZER INC-2015254730,PFIZER,,63.0,YR,,M,Y,,,20150805.0,N,PH,GB,GB,2015,Q3,Adult
113440882,11344088,10,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,2,F,,20150729.0,20150806,20150806,EXP,GB-MHRA-EYC 00126015,GB-ACTAVIS-2015-16361,ACTAVIS,,63.0,YR,,M,Y,,,20150806.0,N,CN,GB,GB,2015,Q3,Adult
113440882,11344088,10,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,U,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,2,F,,20150729.0,20150806,20150806,EXP,GB-MHRA-EYC 00126015,GB-ACTAVIS-2015-16361,ACTAVIS,,63.0,YR,,M,Y,,,20150806.0,N,CN,GB,GB,2015,Q3,Adult
113621331,11362133,10,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150810,20150810,EXP,GB-MHRA-EYC 00126015,PHHY2015GB091309,SANDOZ,,63.0,YR,,M,Y,,,20150810.0,N,OT,GB,GB,2015,Q3,Adult
113621331,11362133,10,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150810,20150810,EXP,GB-MHRA-EYC 00126015,PHHY2015GB091309,SANDOZ,,63.0,YR,,M,Y,,,20150810.0,N,OT,GB,GB,2015,Q3,Adult
113634761,11363476,10,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150811,20150811,EXP,GB-MHRA-EYC 00126015,GB-ACCORD-032775,ACCORD,,63.0,YR,,M,Y,,,20150811.0,N,PH,GB,GB,2015,Q3,Adult
113634761,11363476,10,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150811,20150811,EXP,GB-MHRA-EYC 00126015,GB-ACCORD-032775,ACCORD,,63.0,YR,,M,Y,,,20150811.0,N,PH,GB,GB,2015,Q3,Adult
113637241,11363724,10,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150811,20150811,EXP,,GB-AUROBINDO-AUR-APL-2015-07001,AUROBINDO,,63.0,YR,,M,Y,,,20150811.0,N,PH,GB,GB,2015,Q3,Adult
113637241,11363724,10,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150811,20150811,EXP,,GB-AUROBINDO-AUR-APL-2015-07001,AUROBINDO,,63.0,YR,,M,Y,,,20150811.0,N,PH,GB,GB,2015,Q3,Adult
113661131,11366113,11,C,Exenatide,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150811,20150811,EXP,,GB-BANPHARM-20154095,BANNER,,63.0,YR,A,M,Y,,,20150811.0,N,PH,GB,GB,2015,Q3,Adult
113661131,11366113,11,C,Exenatide,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150811,20150811,EXP,,GB-BANPHARM-20154095,BANNER,,63.0,YR,A,M,Y,,,20150811.0,N,PH,GB,GB,2015,Q3,Adult
113689921,11368992,10,C,Exenatide,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150812,20150812,EXP,GB-MHRA-EYC 00126015,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003998,LUPIN,,63.0,YR,,M,Y,,,20150812.0,N,,GB,GB,2015,Q3,Adult
113689921,11368992,10,C,Exenatide,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150812,20150812,EXP,GB-MHRA-EYC 00126015,GB-LUPIN PHARMACEUTICALS INC.-E2B_00003998,LUPIN,,63.0,YR,,M,Y,,,20150812.0,N,,GB,GB,2015,Q3,Adult
113744401,11374440,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,2006.0,20071102.0,20150813,20150813,PER,,US-ASTRAZENECA-2007BM18460,ASTRAZENECA,,69.0,YR,,F,Y,68.0,KG,20150813.0,N,CN,US,US,2015,Q3,Elderly
113744401,11374440,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injury associated with device,,2015,Q3,1,I,2006.0,20071102.0,20150813,20150813,PER,,US-ASTRAZENECA-2007BM18460,ASTRAZENECA,,69.0,YR,,F,Y,68.0,KG,20150813.0,N,CN,US,US,2015,Q3,Elderly
113744401,11374440,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Nausea,,2015,Q3,1,I,2006.0,20071102.0,20150813,20150813,PER,,US-ASTRAZENECA-2007BM18460,ASTRAZENECA,,69.0,YR,,F,Y,68.0,KG,20150813.0,N,CN,US,US,2015,Q3,Elderly
113744401,11374440,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Product quality issue,,2015,Q3,1,I,2006.0,20071102.0,20150813,20150813,PER,,US-ASTRAZENECA-2007BM18460,ASTRAZENECA,,69.0,YR,,F,Y,68.0,KG,20150813.0,N,CN,US,US,2015,Q3,Elderly
113744691,11374469,11,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150729.0,20150813,20150813,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-053692,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20150813.0,N,CN,GB,GB,2015,Q3,Adult
113744691,11374469,11,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,,,2015,Q3,Hyperkalaemia,,2015,Q3,1,I,,20150729.0,20150813,20150813,EXP,,GB-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-053692,BRISTOL MYERS SQUIBB,,63.0,YR,,M,Y,,,20150813.0,N,CN,GB,GB,2015,Q3,Adult
113777412,11377741,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Abdominal pain upper,,2015,Q3,2,F,20090518.0,20090612.0,20150811,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200906006811,ELI LILLY AND CO,,57.0,YR,,F,Y,70.3,KG,20150825.0,N,CN,US,US,2015,Q3,Adult
113777412,11377741,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Anxiety,,2015,Q3,2,F,20090518.0,20090612.0,20150811,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200906006811,ELI LILLY AND CO,,57.0,YR,,F,Y,70.3,KG,20150825.0,N,CN,US,US,2015,Q3,Adult
113777412,11377741,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Blood glucose decreased,,2015,Q3,2,F,20090518.0,20090612.0,20150811,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200906006811,ELI LILLY AND CO,,57.0,YR,,F,Y,70.3,KG,20150825.0,N,CN,US,US,2015,Q3,Adult
113777412,11377741,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Headache,,2015,Q3,2,F,20090518.0,20090612.0,20150811,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200906006811,ELI LILLY AND CO,,57.0,YR,,F,Y,70.3,KG,20150825.0,N,CN,US,US,2015,Q3,Adult
113777412,11377741,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Malaise,,2015,Q3,2,F,20090518.0,20090612.0,20150811,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200906006811,ELI LILLY AND CO,,57.0,YR,,F,Y,70.3,KG,20150825.0,N,CN,US,US,2015,Q3,Adult
113777412,11377741,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Nausea,,2015,Q3,2,F,20090518.0,20090612.0,20150811,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200906006811,ELI LILLY AND CO,,57.0,YR,,F,Y,70.3,KG,20150825.0,N,CN,US,US,2015,Q3,Adult
113777412,11377741,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Nervousness,,2015,Q3,2,F,20090518.0,20090612.0,20150811,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200906006811,ELI LILLY AND CO,,57.0,YR,,F,Y,70.3,KG,20150825.0,N,CN,US,US,2015,Q3,Adult
113798161,11379816,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Dizziness,,2015,Q3,1,I,20070926.0,20070926.0,20150814,20150814,PER,,US-ASTRAZENECA-2007BM16065,ASTRAZENECA,,15321.0,DY,,F,Y,90.7,KG,20150814.0,N,CN,US,US,2015,Q3,Elderly
113798161,11379816,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Drug dose omission,,2015,Q3,1,I,20070926.0,20070926.0,20150814,20150814,PER,,US-ASTRAZENECA-2007BM16065,ASTRAZENECA,,15321.0,DY,,F,Y,90.7,KG,20150814.0,N,CN,US,US,2015,Q3,Elderly
113798161,11379816,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injection site extravasation,,2015,Q3,1,I,20070926.0,20070926.0,20150814,20150814,PER,,US-ASTRAZENECA-2007BM16065,ASTRAZENECA,,15321.0,DY,,F,Y,90.7,KG,20150814.0,N,CN,US,US,2015,Q3,Elderly
113798161,11379816,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Muscle fatigue,,2015,Q3,1,I,20070926.0,20070926.0,20150814,20150814,PER,,US-ASTRAZENECA-2007BM16065,ASTRAZENECA,,15321.0,DY,,F,Y,90.7,KG,20150814.0,N,CN,US,US,2015,Q3,Elderly
113798161,11379816,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Myalgia,,2015,Q3,1,I,20070926.0,20070926.0,20150814,20150814,PER,,US-ASTRAZENECA-2007BM16065,ASTRAZENECA,,15321.0,DY,,F,Y,90.7,KG,20150814.0,N,CN,US,US,2015,Q3,Elderly
113798161,11379816,3,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,20070926.0,20070926.0,20150814,20150814,PER,,US-ASTRAZENECA-2007BM16065,ASTRAZENECA,,15321.0,DY,,F,Y,90.7,KG,20150814.0,N,CN,US,US,2015,Q3,Elderly
113838391,11383839,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Injection site bruising,,2015,Q3,1,I,20150730.0,20150807.0,20150814,20150814,EXP,,GB-ASTRAZENECA-2015SE76624,ASTRAZENECA,,69.0,YR,,F,Y,92.0,KG,20150814.0,N,MD,GB,GB,2015,Q3,Elderly
113838391,11383839,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Injection site inflammation,,2015,Q3,1,I,20150730.0,20150807.0,20150814,20150814,EXP,,GB-ASTRAZENECA-2015SE76624,ASTRAZENECA,,69.0,YR,,F,Y,92.0,KG,20150814.0,N,MD,GB,GB,2015,Q3,Elderly
113838391,11383839,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,D,,,,,,INJECTION,,2015,Q3,Injection site rash,,2015,Q3,1,I,20150730.0,20150807.0,20150814,20150814,EXP,,GB-ASTRAZENECA-2015SE76624,ASTRAZENECA,,69.0,YR,,F,Y,92.0,KG,20150814.0,N,MD,GB,GB,2015,Q3,Elderly
113891112,11389111,14,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 MCG/0.02 ML, WEEKLY",,,,U,,,,5.0,UG,SOLUTION,,2015,Q3,Rash,,2015,Q3,2,F,20141003.0,20150904.0,20150817,20150915,EXP,,CA-PURDUE PHARMA-CAN-2015-0005998,PURDUE,,66.0,YR,,F,Y,104.8,KG,20150915.0,N,PH,CA,CA,2015,Q3,Elderly
113891112,11389111,14,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 MCG/0.02 ML, WEEKLY",,,,U,,,,5.0,UG,SOLUTION,,2015,Q3,Renal impairment,,2015,Q3,2,F,20141003.0,20150904.0,20150817,20150915,EXP,,CA-PURDUE PHARMA-CAN-2015-0005998,PURDUE,,66.0,YR,,F,Y,104.8,KG,20150915.0,N,PH,CA,CA,2015,Q3,Elderly
113891112,11389111,14,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 MCG/0.02 ML, WEEKLY",,,,U,,,,5.0,UG,SOLUTION,,2015,Q3,Skin irritation,,2015,Q3,2,F,20141003.0,20150904.0,20150817,20150915,EXP,,CA-PURDUE PHARMA-CAN-2015-0005998,PURDUE,,66.0,YR,,F,Y,104.8,KG,20150915.0,N,PH,CA,CA,2015,Q3,Elderly
113973731,11397373,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,INJECTION,,2015,Q3,Asthma,,2015,Q3,1,I,20150807.0,20100629.0,20150819,20150819,PER,,US-ASTRAZENECA-2010BM07596,ASTRAZENECA,,23991.0,DY,,F,Y,289.0,KG,20150819.0,N,,US,US,2015,Q3,Elderly
113973731,11397373,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,INJECTION,,2015,Q3,Drug dose omission,,2015,Q3,1,I,20150807.0,20100629.0,20150819,20150819,PER,,US-ASTRAZENECA-2010BM07596,ASTRAZENECA,,23991.0,DY,,F,Y,289.0,KG,20150819.0,N,,US,US,2015,Q3,Elderly
113973731,11397373,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,INJECTION,,2015,Q3,Feeling abnormal,,2015,Q3,1,I,20150807.0,20100629.0,20150819,20150819,PER,,US-ASTRAZENECA-2010BM07596,ASTRAZENECA,,23991.0,DY,,F,Y,289.0,KG,20150819.0,N,,US,US,2015,Q3,Elderly
113973731,11397373,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,INJECTION,,2015,Q3,Intentional product misuse,,2015,Q3,1,I,20150807.0,20100629.0,20150819,20150819,PER,,US-ASTRAZENECA-2010BM07596,ASTRAZENECA,,23991.0,DY,,F,Y,289.0,KG,20150819.0,N,,US,US,2015,Q3,Elderly
113973731,11397373,6,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,,,INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,20150807.0,20100629.0,20150819,20150819,PER,,US-ASTRAZENECA-2010BM07596,ASTRAZENECA,,23991.0,DY,,F,Y,289.0,KG,20150819.0,N,,US,US,2015,Q3,Elderly
113974662,11397466,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,254.0,MG,,D,,,,2.0,MG,INJECTION,/wk,2015,Q3,Pancreatitis,,2015,Q3,2,F,201507.0,20150909.0,20150819,20150917,EXP,,AT-ASTRAZENECA-2015SE77709,ASTRAZENECA,,66.0,YR,,M,Y,94.0,KG,20150917.0,N,MD,AT,AT,2015,Q3,Elderly
114290921,11429092,6,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,,20121226.0,20150828,20150828,PER,,US-ASTRAZENECA-2013SE28678,ASTRAZENECA,,28822.0,DY,,F,Y,63.5,KG,20150828.0,N,,US,US,2015,Q3,Elderly
114290921,11429092,6,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Drug dose omission,,2015,Q3,1,I,,20121226.0,20150828,20150828,PER,,US-ASTRAZENECA-2013SE28678,ASTRAZENECA,,28822.0,DY,,F,Y,63.5,KG,20150828.0,N,,US,US,2015,Q3,Elderly
114290921,11429092,6,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Drug ineffective,,2015,Q3,1,I,,20121226.0,20150828,20150828,PER,,US-ASTRAZENECA-2013SE28678,ASTRAZENECA,,28822.0,DY,,F,Y,63.5,KG,20150828.0,N,,US,US,2015,Q3,Elderly
114290921,11429092,6,C,"EXENATIDE 10MCG PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,,,2015,Q3,Product quality issue,,2015,Q3,1,I,,20121226.0,20150828,20150828,PER,,US-ASTRAZENECA-2013SE28678,ASTRAZENECA,,28822.0,DY,,F,Y,63.5,KG,20150828.0,N,,US,US,2015,Q3,Elderly
114445631,11444563,5,C,Exenatide,EXENATIDE,1,Unknown,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acidosis,,2015,Q3,1,I,,20150819.0,20150902,20150902,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2015-02609,LUPIN,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015;210229:1-5.",44.0,YR,,M,Y,,,20150902.0,N,OT,AU,AU,2015,Q3,Adult
114445631,11444563,5,C,Exenatide,EXENATIDE,1,Unknown,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150819.0,20150902,20150902,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2015-02609,LUPIN,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015;210229:1-5.",44.0,YR,,M,Y,,,20150902.0,N,OT,AU,AU,2015,Q3,Adult
114445631,11444563,5,C,Exenatide,EXENATIDE,1,Unknown,,,,,D,,,,10.0,UG,,BID,2015,Q3,Distributive shock,,2015,Q3,1,I,,20150819.0,20150902,20150902,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2015-02609,LUPIN,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015;210229:1-5.",44.0,YR,,M,Y,,,20150902.0,N,OT,AU,AU,2015,Q3,Adult
114445631,11444563,5,C,Exenatide,EXENATIDE,1,Unknown,,,,,D,,,,10.0,UG,,BID,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,,20150819.0,20150902,20150902,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2015-02609,LUPIN,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015;210229:1-5.",44.0,YR,,M,Y,,,20150902.0,N,OT,AU,AU,2015,Q3,Adult
114445631,11444563,5,C,Exenatide,EXENATIDE,1,Unknown,,,,,D,,,,10.0,UG,,BID,2015,Q3,Overdose,,2015,Q3,1,I,,20150819.0,20150902,20150902,EXP,,AU-LUPIN PHARMACEUTICALS INC.-2015-02609,LUPIN,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ CASE REP. 2015;210229:1-5.",44.0,YR,,M,Y,,,20150902.0,N,OT,AU,AU,2015,Q3,Adult
114460231,11446023,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,,BID,2015,Q3,Cholecystectomy,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114460231,11446023,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,,BID,2015,Q3,Pain,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114460231,11446023,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,,BID,2015,Q3,Tremor,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114460231,11446023,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,,BID,2015,Q3,Vomiting,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114460231,11446023,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, 2/D",,,,D,,,,10.0,UG,,BID,2015,Q3,Cholecystectomy,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114460231,11446023,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, 2/D",,,,D,,,,10.0,UG,,BID,2015,Q3,Pain,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114460231,11446023,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, 2/D",,,,D,,,,10.0,UG,,BID,2015,Q3,Tremor,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114460231,11446023,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, 2/D",,,,D,,,,10.0,UG,,BID,2015,Q3,Vomiting,,2015,Q3,1,I,200804.0,20080819.0,20150831,20150831,PER,,US-ELI_LILLY_AND_COMPANY-US200808006159,ELI LILLY AND CO,,64.0,YR,,F,Y,102.49,KG,20150814.0,N,CN,US,US,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Acute lung injury,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Distributive shock,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Encephalopathy,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Intentional overdose,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Lactic acidosis,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Metabolic acidosis,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Pulmonary hypertension,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Respiratory failure,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Tachyarrhythmia,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114559611,11455961,5,C,EXENATIDE,EXENATIDE,1,Unknown,"10 ?G, BID",,,,U,,,,10.0,UG,,Q12H,2015,Q3,Vasoplegia syndrome,,2015,Q3,1,I,,20150819.0,20150903,20150903,EXP,,AU-APOTEX-2015AP012530,APOTEX,,44.0,YR,,M,Y,,,20150903.0,N,CN,GB,AU,2015,Q3,Adult
114590191,11459019,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,200709.0,20080527.0,20150904,20150904,PER,,US-ASTRAZENECA-2008BM07484,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20150904.0,N,,US,US,2015,Q3,Adult
114590191,11459019,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Drug effect decreased,,2015,Q3,1,I,200709.0,20080527.0,20150904,20150904,PER,,US-ASTRAZENECA-2008BM07484,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20150904.0,N,,US,US,2015,Q3,Adult
114590191,11459019,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Glycosylated haemoglobin increased,,2015,Q3,1,I,200709.0,20080527.0,20150904,20150904,PER,,US-ASTRAZENECA-2008BM07484,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20150904.0,N,,US,US,2015,Q3,Adult
114590191,11459019,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Injection site nodule,,2015,Q3,1,I,200709.0,20080527.0,20150904,20150904,PER,,US-ASTRAZENECA-2008BM07484,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20150904.0,N,,US,US,2015,Q3,Adult
114590191,11459019,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Nausea,,2015,Q3,1,I,200709.0,20080527.0,20150904,20150904,PER,,US-ASTRAZENECA-2008BM07484,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20150904.0,N,,US,US,2015,Q3,Adult
114590191,11459019,8,C,"EXENATIDE 5mcg PEN, DISPOSABLE DEVICE",EXENATIDE,1,,,,,,D,,,,,,SOLUTION FOR INJECTION,,2015,Q3,Vomiting,,2015,Q3,1,I,200709.0,20080527.0,20150904,20150904,PER,,US-ASTRAZENECA-2008BM07484,ASTRAZENECA,,63.0,YR,,F,Y,63.5,KG,20150904.0,N,,US,US,2015,Q3,Adult
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Back injury,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Back pain,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose decreased,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Decreased appetite,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Drug dose omission,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Dyspepsia,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Exostosis,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Intervertebral disc degeneration,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Memory impairment,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Neck injury,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Neck pain,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Pain in extremity,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Product quality issue,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Road traffic accident,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114875661,11487566,5,C,EXENATIDE,EXENATIDE,1,,,,,,D, A753318A,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,201011.0,20110126.0,20150910,20150910,PER,,US-ASTRAZENECA-2011BM04930,ASTRAZENECA,,864.0,MON,,M,Y,71.7,KG,20150910.0,N,,US,US,2015,Q3,Elderly
114922881,11492288,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Blood glucose fluctuation,,2015,Q3,1,I,,20150427.0,20150910,20150910,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-034580,BRISTOL MYERS SQUIBB,,38.0,YR,,F,Y,74.0,KG,20150910.0,N,CN,DE,JP,2015,Q3,Adult
114922881,11492288,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Gestational hypertension,,2015,Q3,1,I,,20150427.0,20150910,20150910,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-034580,BRISTOL MYERS SQUIBB,,38.0,YR,,F,Y,74.0,KG,20150910.0,N,CN,DE,JP,2015,Q3,Adult
114922881,11492288,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Maternal exposure during pregnancy,,2015,Q3,1,I,,20150427.0,20150910,20150910,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-034580,BRISTOL MYERS SQUIBB,,38.0,YR,,F,Y,74.0,KG,20150910.0,N,CN,DE,JP,2015,Q3,Adult
114922881,11492288,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Normal newborn,,2015,Q3,1,I,,20150427.0,20150910,20150910,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-034580,BRISTOL MYERS SQUIBB,,38.0,YR,,F,Y,74.0,KG,20150910.0,N,CN,DE,JP,2015,Q3,Adult
114922881,11492288,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,D,,,,,,,,2015,Q3,Retinopathy,,2015,Q3,1,I,,20150427.0,20150910,20150910,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-034580,BRISTOL MYERS SQUIBB,,38.0,YR,,F,Y,74.0,KG,20150910.0,N,CN,DE,JP,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Abdominal pain,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute kidney injury,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Acute lung injury,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Distributive shock,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Ejection fraction decreased,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Encephalopathy,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Fluid overload,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Haemodynamic instability,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Hypoglycaemia,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Intentional overdose,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Lactic acidosis,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Pulmonary hypertension,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Respiratory failure,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Respiratory gas exchange disorder,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Right ventricular dysfunction,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
114983011,11498301,5,C,EXENATIDE,EXENATIDE,1,,,,,,D,,,,10.0,UG,,BID,2015,Q3,Vomiting,,2015,Q3,1,I,,20150827.0,20150911,20150911,EXP,,AU-BAUSCH-BL-2015-020476,BAUSCH AND LOMB,"GRAHAM R, CARTNER M, WINEARLS J. A SEVERE CASE OF VASOPLEGIC SHOCK FOLLOWING METFORMIN OVERDOSE SUCCESSFULLY TREATED WITH METHYLENE BLUE AS A LAST LINE THERAPY. BMJ. 2015;1-5.",44.0,YR,,M,Y,,,20150911.0,N,MD,AU,AU,2015,Q3,Adult
115020581,11502058,4,C,EXENATIDE,EXENATIDE,1,,"10 MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q3,Blood glucose increased,,2015,Q3,1,I,201205.0,20121203.0,20150914,20150914,PER,,US-ASTRAZENECA-2012BM15373,ASTRAZENECA,,757.0,MON,,F,Y,71.2,KG,20150914.0,N,,US,US,2015,Q3,Elderly
115020581,11502058,4,C,EXENATIDE,EXENATIDE,1,,"10 MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q3,Crying,,2015,Q3,1,I,201205.0,20121203.0,20150914,20150914,PER,,US-ASTRAZENECA-2012BM15373,ASTRAZENECA,,757.0,MON,,F,Y,71.2,KG,20150914.0,N,,US,US,2015,Q3,Elderly
115020581,11502058,4,C,EXENATIDE,EXENATIDE,1,,"10 MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q3,Drug dose omission,,2015,Q3,1,I,201205.0,20121203.0,20150914,20150914,PER,,US-ASTRAZENECA-2012BM15373,ASTRAZENECA,,757.0,MON,,F,Y,71.2,KG,20150914.0,N,,US,US,2015,Q3,Elderly
115020581,11502058,4,C,EXENATIDE,EXENATIDE,1,,"10 MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q3,Feeling abnormal,,2015,Q3,1,I,201205.0,20121203.0,20150914,20150914,PER,,US-ASTRAZENECA-2012BM15373,ASTRAZENECA,,757.0,MON,,F,Y,71.2,KG,20150914.0,N,,US,US,2015,Q3,Elderly
115020581,11502058,4,C,EXENATIDE,EXENATIDE,1,,"10 MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,INJECTION,,2015,Q3,Weight decreased,,2015,Q3,1,I,201205.0,20121203.0,20150914,20150914,PER,,US-ASTRAZENECA-2012BM15373,ASTRAZENECA,,757.0,MON,,F,Y,71.2,KG,20150914.0,N,,US,US,2015,Q3,Elderly
115084921,11508492,4,C,EXENATIDE,EXENATIDE,1,,UNK,,,,D,,,,,,,,2015,Q3,Jaundice,,2015,Q3,1,I,20150725.0,20150908.0,20150915,20150915,EXP,GB-MHRA-EYC 00127441,GB-PFIZER INC-2015301376,PFIZER,,60.0,YR,,F,Y,58.0,KG,20150915.0,N,OT,GB,GB,2015,Q3,Adult
115084921,11508492,4,C,EXENATIDE,EXENATIDE,1,,UNK,,,,D,,,,,,,,2015,Q3,Lethargy,,2015,Q3,1,I,20150725.0,20150908.0,20150915,20150915,EXP,GB-MHRA-EYC 00127441,GB-PFIZER INC-2015301376,PFIZER,,60.0,YR,,F,Y,58.0,KG,20150915.0,N,OT,GB,GB,2015,Q3,Adult
115084921,11508492,4,C,EXENATIDE,EXENATIDE,1,,UNK,,,,D,,,,,,,,2015,Q3,Liver function test abnormal,,2015,Q3,1,I,20150725.0,20150908.0,20150915,20150915,EXP,GB-MHRA-EYC 00127441,GB-PFIZER INC-2015301376,PFIZER,,60.0,YR,,F,Y,58.0,KG,20150915.0,N,OT,GB,GB,2015,Q3,Adult
115084921,11508492,4,C,EXENATIDE,EXENATIDE,1,,UNK,,,,D,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,20150725.0,20150908.0,20150915,20150915,EXP,GB-MHRA-EYC 00127441,GB-PFIZER INC-2015301376,PFIZER,,60.0,YR,,F,Y,58.0,KG,20150915.0,N,OT,GB,GB,2015,Q3,Adult
115122971,11512297,4,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q3,Jaundice,,2015,Q3,1,I,20150725.0,20150908.0,20150916,20150916,EXP,,GB-AUROBINDO-AUR-APL-2015-08123,AUROBINDO,,60.0,YR,,F,Y,58.0,KG,20150916.0,N,OT,GB,GB,2015,Q3,Adult
115122971,11512297,4,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q3,Lethargy,,2015,Q3,1,I,20150725.0,20150908.0,20150916,20150916,EXP,,GB-AUROBINDO-AUR-APL-2015-08123,AUROBINDO,,60.0,YR,,F,Y,58.0,KG,20150916.0,N,OT,GB,GB,2015,Q3,Adult
115122971,11512297,4,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q3,Liver function test abnormal,,2015,Q3,1,I,20150725.0,20150908.0,20150916,20150916,EXP,,GB-AUROBINDO-AUR-APL-2015-08123,AUROBINDO,,60.0,YR,,F,Y,58.0,KG,20150916.0,N,OT,GB,GB,2015,Q3,Adult
115122971,11512297,4,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,20150725.0,20150908.0,20150916,20150916,EXP,,GB-AUROBINDO-AUR-APL-2015-08123,AUROBINDO,,60.0,YR,,F,Y,58.0,KG,20150916.0,N,OT,GB,GB,2015,Q3,Adult
115307281,11530728,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,INJECTION,BID,2015,Q3,Hunger,,2015,Q3,1,I,200812.0,20090217.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200902004896,ELI LILLY AND CO,,65.0,YR,,F,Y,83.9,KG,20150824.0,N,CN,US,US,2015,Q3,Elderly
115307281,11530728,3,C,EXENATIDE,EXENATIDE,1,,"10 UG, 2/D",,,,D,,,,10.0,UG,INJECTION,BID,2015,Q3,Hunger,,2015,Q3,1,I,200812.0,20090217.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US200902004896,ELI LILLY AND CO,,65.0,YR,,F,Y,83.9,KG,20150824.0,N,CN,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Abdominal discomfort,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Abdominal pain,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Chest discomfort,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Decreased activity,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Diarrhoea,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Discomfort,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Dizziness,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Dyspepsia,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Dyspnoea,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Fear,Fear,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Feeding disorder,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Hypersomnia,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Malaise,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115340721,11534072,4,C,EXENATIDE,EXENATIDE,1,,"5MCG PEN, DISPOSABLE DEVICE",,,,D,,,,,,,,2015,Q3,Nausea,,2015,Q3,1,I,200803.0,20080325.0,20150922,20150922,PER,,US-ASTRAZENECA-2008BM04418,ASTRAZENECA,,77.0,YR,,F,Y,99.8,KG,20150922.0,N,,US,US,2015,Q3,Elderly
115520521,11552052,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,,BID,2015,Q3,Dizziness,,2015,Q3,1,I,20100608.0,20100608.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201006002893,ELI LILLY AND CO,,67.0,YR,,F,Y,96.6,KG,20150827.0,N,CN,US,US,2015,Q3,Elderly
115520521,11552052,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,,BID,2015,Q3,Headache,,2015,Q3,1,I,20100608.0,20100608.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201006002893,ELI LILLY AND CO,,67.0,YR,,F,Y,96.6,KG,20150827.0,N,CN,US,US,2015,Q3,Elderly
115520521,11552052,2,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"5 UG, 2/D",,,,D,,,,5.0,UG,,BID,2015,Q3,Nervousness,,2015,Q3,1,I,20100608.0,20100608.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201006002893,ELI LILLY AND CO,,67.0,YR,,F,Y,96.6,KG,20150827.0,N,CN,US,US,2015,Q3,Elderly
115520521,11552052,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, 2/D",,,,D,,,,10.0,UG,,BID,2015,Q3,Dizziness,,2015,Q3,1,I,20100608.0,20100608.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201006002893,ELI LILLY AND CO,,67.0,YR,,F,Y,96.6,KG,20150827.0,N,CN,US,US,2015,Q3,Elderly
115520521,11552052,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, 2/D",,,,D,,,,10.0,UG,,BID,2015,Q3,Headache,,2015,Q3,1,I,20100608.0,20100608.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201006002893,ELI LILLY AND CO,,67.0,YR,,F,Y,96.6,KG,20150827.0,N,CN,US,US,2015,Q3,Elderly
115520521,11552052,3,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, 2/D",,,,D,,,,10.0,UG,,BID,2015,Q3,Nervousness,,2015,Q3,1,I,20100608.0,20100608.0,20150903,20150903,PER,,US-ELI_LILLY_AND_COMPANY-US201006002893,ELI LILLY AND CO,,67.0,YR,,F,Y,96.6,KG,20150827.0,N,CN,US,US,2015,Q3,Elderly
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Angina pectoris,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Arthralgia,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Constipation,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Diabetes mellitus,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Diarrhoea,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Eczema,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Gastroenteritis,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Gastroenteritis viral,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Glucose urine present,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Glycosylated haemoglobin increased,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Headache,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Hypertension,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Iron deficiency anaemia,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Large intestine polyp,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Nasopharyngitis,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Nausea,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Oedema,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Off label use,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Premenstrual syndrome,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Temporomandibular joint syndrome,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Upper respiratory tract infection,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Vomiting,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
99344765,9934476,38,C,BYETTA (EXENATIDE),,2,,,,,,,,,,,,,,2015,Q3,Vulvovaginal candidiasis,,2015,Q3,5,F,20080428.0,20150731.0,20140226,20150817,EXP,,2010JP004032,ASTELLAS,,37.0,YR,,F,N,84.0,KG,20150812.0,N,MD,JP,,2015,Q3,Adult
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Blood glucose increased,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Disturbance in attention,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Dizziness,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Feeling abnormal,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Gout,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Influenza like illness,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Injection site haemorrhage,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Nausea,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Osteomyelitis,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Product quality issue,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Renal impairment,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Soft tissue infection,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Underdose,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Weight decreased,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
110938512,11093851,8,C,EXENATIDE,EXENATIDE,1,,10 MCG,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Weight increased,,2015,Q4,2,F,200506.0,20151002.0,20150506,20151009,EXP,,US-ASTRAZENECA-2007BM13497,ASTRAZENECA,,640.0,MON,,M,Y,147.4,KG,20151009.0,,CN,US,US,2015,Q4,Elderly
112557362,11255736,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, TWO TIMES A DAY, UNIT 4",46259.167,UG,,,,,,,,INJECTION,,2015,Q4,Deep vein thrombosis,,2015,Q4,2,F,20150601.0,20150724.0,20150709,20151008,EXP,,GB-ASTRAZENECA-2015SE64624,ASTRAZENECA,,69.0,YR,,F,Y,63.8,KG,20151008.0,,MD,GB,GB,2015,Q4,Elderly
112557362,11255736,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, TWO TIMES A DAY, UNIT 4",46259.167,UG,,,,,,,,INJECTION,,2015,Q4,Pancreatic carcinoma metastatic,,2015,Q4,2,F,20150601.0,20150724.0,20150709,20151008,EXP,,GB-ASTRAZENECA-2015SE64624,ASTRAZENECA,,69.0,YR,,F,Y,63.8,KG,20151008.0,,MD,GB,GB,2015,Q4,Elderly
112557362,11255736,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 UG, TWO TIMES A DAY, UNIT 4",46259.167,UG,,,,,,,,INJECTION,,2015,Q4,Pulmonary embolism,,2015,Q4,2,F,20150601.0,20150724.0,20150709,20151008,EXP,,GB-ASTRAZENECA-2015SE64624,ASTRAZENECA,,69.0,YR,,F,Y,63.8,KG,20151008.0,,MD,GB,GB,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Feeling abnormal,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Incorrect dose administered,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Injection site extravasation,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Injection site mass,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Injection site pain,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Intentional product misuse,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Product quality issue,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
113092563,11309256,6,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,10.0,UG,SOLUTION FOR INJECTION,,2015,Q4,Underdose,,2015,Q4,3,F,200910.0,20151013.0,20150724,20151028,PER,,US-ASTRAZENECA-2009BM12328,ASTRAZENECA,,757.0,MON,,F,Y,90.7,KG,20151028.0,,,US,US,2015,Q4,Elderly
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Abdominal pain,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Acute kidney injury,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Distributive shock,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Hypoglycaemia,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Intentional overdose,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Metabolic acidosis,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Tachyarrhythmia,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
114280362,11428036,3,C,EXENATIDE,EXENATIDE,1,Unknown,"10 MCG, BID",,,,U,,,,,,,BID,2015,Q4,Vomiting,,2015,Q4,2,F,,20151005.0,20150828,20151019,EXP,,AU-ACTAVIS PTY LTD-2015-18159,WATSON,,44.0,YR,,M,Y,,,20151019.0,,MD,AU,AU,2015,Q4,Adult
116745721,11674572,2,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Glycosylated haemoglobin increased,,2015,Q4,1,I,,20151020.0,20151028,20151028,EXP,,IT-ASTRAZENECA-2015SF02597,ASTRAZENECA,,38.0,YR,,M,Y,,,20151028.0,,,IT,IT,2015,Q4,Adult
116745721,11674572,2,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Hypoglycaemia,,2015,Q4,1,I,,20151020.0,20151028,20151028,EXP,,IT-ASTRAZENECA-2015SF02597,ASTRAZENECA,,38.0,YR,,M,Y,,,20151028.0,,,IT,IT,2015,Q4,Adult
116745721,11674572,2,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Low density lipoprotein increased,,2015,Q4,1,I,,20151020.0,20151028,20151028,EXP,,IT-ASTRAZENECA-2015SF02597,ASTRAZENECA,,38.0,YR,,M,Y,,,20151028.0,,,IT,IT,2015,Q4,Adult
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Blood glucose decreased,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Blood glucose increased,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Device difficult to use,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Gastrointestinal sounds abnormal,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Incorrect dose administered,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Injection site bruising,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Injection site haemorrhage,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Injury associated with device,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Product quality issue,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116804812,11680481,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,,,2015,Q4,Weight decreased,,2015,Q4,2,F,20130108.0,20151026.0,20151029,20151124,PER,,US-ASTRAZENECA-2014SE86142,ASTRAZENECA,,19601.0,DY,,F,Y,74.8,KG,20151124.0,,,US,US,2015,Q4,Elderly
116858601,11685860,2,SS,EXENATIDE,EXENATIDE,1,Subcutaneous,"10 ?G, BID",,,,U, UNKNOWN,,,10.0,UG,,BID,2015,Q4,Pancreatic mass,,2015,Q4,1,I,201509.0,20151020.0,20151030,20151030,EXP,GB-MHRA-EYC 00129220,GB-NOVOPROD-467986,NOVO NORDISK,,61.0,YR,A,M,Y,105.0,KG,20151030.0,,OT,GB,GB,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Abdominal distension,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Dyspepsia,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Feeling abnormal,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Hyperhidrosis,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Injection site erythema,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Injection site pruritus,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Malaise,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116882442,11688244,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,INJECTION,,2015,Q4,Nausea,,2015,Q4,2,F,200709.0,20151023.0,20151030,20151110,EXP,,US-ASTRAZENECA-2007BM16591,ASTRAZENECA,,63.0,YR,,M,Y,113.4,KG,20151110.0,,CN,US,US,2015,Q4,Adult
116972522,11697252,13,C,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,2,F,20131108.0,20151221.0,20151104,20151229,PER,,US-JNJFOC-20151024507,JANSSEN,,63.0,YR,A,F,Y,,,20151229.0,,CN,US,US,2015,Q4,Adult
117041631,11704163,7,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Internal haemorrhage,,2015,Q4,1,I,20141114.0,20150906.0,20151106,20151106,EXP,,US-BAYER-2015-421339,BAYER,,55.0,YR,A,M,Y,,,20151106.0,,OT,US,US,2015,Q4,Adult
117041631,11704163,7,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Lower gastrointestinal haemorrhage,,2015,Q4,1,I,20141114.0,20150906.0,20151106,20151106,EXP,,US-BAYER-2015-421339,BAYER,,55.0,YR,A,M,Y,,,20151106.0,,OT,US,US,2015,Q4,Adult
117051533,11705153,18,SS,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2015,Q4,Acute kidney injury,,2015,Q4,3,F,20150416.0,20151126.0,20151106,20151201,EXP,,US-ASTELLAS-2015US040202,ASTELLAS,,70.0,YR,,M,Y,117.0,KG,20151201.0,,CN,US,US,2015,Q4,Elderly
117051533,11705153,18,SS,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2015,Q4,Cholecystitis acute,,2015,Q4,3,F,20150416.0,20151126.0,20151106,20151201,EXP,,US-ASTELLAS-2015US040202,ASTELLAS,,70.0,YR,,M,Y,117.0,KG,20151201.0,,CN,US,US,2015,Q4,Elderly
117051533,11705153,18,SS,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN FREQ.",,,,,,,,,,FORMULATION UNKNOWN,,2015,Q4,Pancreatitis acute,,2015,Q4,3,F,20150416.0,20151126.0,20151106,20151201,EXP,,US-ASTELLAS-2015US040202,ASTELLAS,,70.0,YR,,M,Y,117.0,KG,20151201.0,,CN,US,US,2015,Q4,Elderly
117428052,11742805,17,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Acute kidney injury,,2015,Q4,2,F,20150416.0,20151209.0,20151116,20151216,PER,,US-JNJFOC-20151111509,JANSSEN,,70.0,YR,E,M,Y,117.0,KG,20151216.0,,MD,US,US,2015,Q4,Elderly
117428052,11742805,17,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Cholecystitis acute,,2015,Q4,2,F,20150416.0,20151209.0,20151116,20151216,PER,,US-JNJFOC-20151111509,JANSSEN,,70.0,YR,E,M,Y,117.0,KG,20151216.0,,MD,US,US,2015,Q4,Elderly
117428052,11742805,17,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,UNSPECIFIED,,2015,Q4,Pancreatitis acute,,2015,Q4,2,F,20150416.0,20151209.0,20151116,20151216,PER,,US-JNJFOC-20151111509,JANSSEN,,70.0,YR,E,M,Y,117.0,KG,20151216.0,,MD,US,US,2015,Q4,Elderly
117697052,11769705,2,C,EXENATIDE,EXENATIDE,1,,UNK,,,,,,,,,,,,2015,Q4,Product use issue,,2015,Q4,2,F,2012.0,20151116.0,20151123,20151127,PER,,US-BAYER-2015-471344,BAYER,,89.0,YR,E,M,Y,117.91,KG,20151123.0,,CN,US,US,2015,Q4,Elderly
117744192,11774419,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Acute kidney injury,,2015,Q4,2,F,20150416.0,20151209.0,20151124,20151217,EXP,,US-ASTRAZENECA-2015SF12186,ASTRAZENECA,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
117744192,11774419,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Cholecystitis acute,,2015,Q4,2,F,20150416.0,20151209.0,20151124,20151217,EXP,,US-ASTRAZENECA-2015SF12186,ASTRAZENECA,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
117744192,11774419,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Decreased appetite,,2015,Q4,2,F,20150416.0,20151209.0,20151124,20151217,EXP,,US-ASTRAZENECA-2015SF12186,ASTRAZENECA,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
117744192,11774419,1,PS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,INJECTION,,2015,Q4,Pancreatitis acute,,2015,Q4,2,F,20150416.0,20151209.0,20151124,20151217,EXP,,US-ASTRAZENECA-2015SF12186,ASTRAZENECA,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
117774101,11777410,18,SS,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,20150416.0,20151116.0,20151125,20151125,EXP,,US-ELI_LILLY_AND_COMPANY-US201511005631,ELI LILLY AND CO,,70.0,YR,,M,Y,117.0,KG,20151124.0,,CN,US,US,2015,Q4,Elderly
117774101,11777410,18,SS,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Cholecystitis acute,,2015,Q4,1,I,20150416.0,20151116.0,20151125,20151125,EXP,,US-ELI_LILLY_AND_COMPANY-US201511005631,ELI LILLY AND CO,,70.0,YR,,M,Y,117.0,KG,20151124.0,,CN,US,US,2015,Q4,Elderly
117774101,11777410,18,SS,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,1,I,20150416.0,20151116.0,20151125,20151125,EXP,,US-ELI_LILLY_AND_COMPANY-US201511005631,ELI LILLY AND CO,,70.0,YR,,M,Y,117.0,KG,20151124.0,,CN,US,US,2015,Q4,Elderly
117816221,11781622,1,PS,EXENATIDE,EXENATIDE,1,Unknown,VIAL AND SOLVENT,,,,,,,21773.0,,,INJECTION,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,,20151119.0,20151126,20151126,EXP,,GB-ASTRAZENECA-2015SF12928,ASTRAZENECA,,68.0,YR,,,Y,,,20151126.0,,PH,GB,GB,2015,Q4,Elderly
117816221,11781622,1,PS,EXENATIDE,EXENATIDE,1,Unknown,VIAL AND SOLVENT,,,,,,,21773.0,,,INJECTION,,2015,Q4,Product substitution issue,,2015,Q4,1,I,,20151119.0,20151126,20151126,EXP,,GB-ASTRAZENECA-2015SF12928,ASTRAZENECA,,68.0,YR,,,Y,,,20151126.0,,PH,GB,GB,2015,Q4,Elderly
117816221,11781622,2,SS,EXENATIDE,EXENATIDE,1,Unknown,PRE-FILLED PEN,,,,,,,21773.0,,,INJECTION,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,,20151119.0,20151126,20151126,EXP,,GB-ASTRAZENECA-2015SF12928,ASTRAZENECA,,68.0,YR,,,Y,,,20151126.0,,PH,GB,GB,2015,Q4,Elderly
117816221,11781622,2,SS,EXENATIDE,EXENATIDE,1,Unknown,PRE-FILLED PEN,,,,,,,21773.0,,,INJECTION,,2015,Q4,Product substitution issue,,2015,Q4,1,I,,20151119.0,20151126,20151126,EXP,,GB-ASTRAZENECA-2015SF12928,ASTRAZENECA,,68.0,YR,,,Y,,,20151126.0,,PH,GB,GB,2015,Q4,Elderly
117829081,11782908,2,SS,EXENATIDE,EXENATIDE,1,Unknown,DOSE WAS 10 (UNITS UNSPECIFIED),,,,,,,,,,UNKNOWN,,2015,Q4,Anaemia,,2015,Q4,1,I,201508.0,20151124.0,20151127,20151127,EXP,,GB-JNJFOC-20151123164,JANSSEN,,61.0,YR,A,F,Y,66.8,KG,20151127.0,,PH,GB,GB,2015,Q4,Adult
117829081,11782908,2,SS,EXENATIDE,EXENATIDE,1,Unknown,DOSE WAS 10 (UNITS UNSPECIFIED),,,,,,,,,,UNKNOWN,,2015,Q4,Colon cancer,,2015,Q4,1,I,201508.0,20151124.0,20151127,20151127,EXP,,GB-JNJFOC-20151123164,JANSSEN,,61.0,YR,A,F,Y,66.8,KG,20151127.0,,PH,GB,GB,2015,Q4,Adult
117880871,11788087,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,, 72841,,22200.0,2.0,MG,INJECTION,/wk,2015,Q4,Blood pressure increased,,2015,Q4,1,I,20120610.0,20120612.0,20151130,20151130,PER,,US-ASTRAZENECA-2012BM09777,ASTRAZENECA,,20587.0,DY,,M,Y,117.9,KG,20151201.0,,,US,US,2015,Q4,Elderly
117880871,11788087,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,, 72841,,22200.0,2.0,MG,INJECTION,/wk,2015,Q4,Injection site haemorrhage,,2015,Q4,1,I,20120610.0,20120612.0,20151130,20151130,PER,,US-ASTRAZENECA-2012BM09777,ASTRAZENECA,,20587.0,DY,,M,Y,117.9,KG,20151201.0,,,US,US,2015,Q4,Elderly
117880871,11788087,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,, 72841,,22200.0,2.0,MG,INJECTION,/wk,2015,Q4,Injection site pain,,2015,Q4,1,I,20120610.0,20120612.0,20151130,20151130,PER,,US-ASTRAZENECA-2012BM09777,ASTRAZENECA,,20587.0,DY,,M,Y,117.9,KG,20151201.0,,,US,US,2015,Q4,Elderly
117891382,11789138,12,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Abdominal pain,,2015,Q4,2,F,20150416.0,20151208.0,20151201,20151222,EXP,,US-AUROBINDO-AUR-APL-2015-10764,AUROBINDO,,70.0,YR,,M,Y,,,20151221.0,,OT,US,US,2015,Q4,Elderly
117891382,11789138,12,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,2,F,20150416.0,20151208.0,20151201,20151222,EXP,,US-AUROBINDO-AUR-APL-2015-10764,AUROBINDO,,70.0,YR,,M,Y,,,20151221.0,,OT,US,US,2015,Q4,Elderly
117891382,11789138,12,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Cholecystitis acute,,2015,Q4,2,F,20150416.0,20151208.0,20151201,20151222,EXP,,US-AUROBINDO-AUR-APL-2015-10764,AUROBINDO,,70.0,YR,,M,Y,,,20151221.0,,OT,US,US,2015,Q4,Elderly
117891382,11789138,12,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Decreased appetite,,2015,Q4,2,F,20150416.0,20151208.0,20151201,20151222,EXP,,US-AUROBINDO-AUR-APL-2015-10764,AUROBINDO,,70.0,YR,,M,Y,,,20151221.0,,OT,US,US,2015,Q4,Elderly
117891382,11789138,12,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,U,,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,2,F,20150416.0,20151208.0,20151201,20151222,EXP,,US-AUROBINDO-AUR-APL-2015-10764,AUROBINDO,,70.0,YR,,M,Y,,,20151221.0,,OT,US,US,2015,Q4,Elderly
118033713,11803371,19,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,, UNK,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,3,F,20150416.0,20151214.0,20151204,20151223,EXP,,US-SA-2015SA195859,AVENTIS,,70.0,YR,E,M,Y,117.0,KG,20151223.0,,MD,US,US,2015,Q4,Elderly
118033713,11803371,19,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,, UNK,,,,,,,2015,Q4,Cholecystitis acute,,2015,Q4,3,F,20150416.0,20151214.0,20151204,20151223,EXP,,US-SA-2015SA195859,AVENTIS,,70.0,YR,E,M,Y,117.0,KG,20151223.0,,MD,US,US,2015,Q4,Elderly
118033713,11803371,19,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,, UNK,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,3,F,20150416.0,20151214.0,20151204,20151223,EXP,,US-SA-2015SA195859,AVENTIS,,70.0,YR,E,M,Y,117.0,KG,20151223.0,,MD,US,US,2015,Q4,Elderly
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Arthralgia,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Dizziness,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Drug ineffective for unapproved indication,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Fatigue,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Headache,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Nausea,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Peripheral swelling,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Product quality issue,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Vomiting,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118048281,11804828,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U, 9RW60M,,21773.0,5.0,UG,INJECTION,BID,2015,Q4,Weight decreased,,2015,Q4,1,I,200604.0,20060505.0,20151205,20151205,PER,,US-ASTRAZENECA-2006BM07235,ASTRAZENECA,,64.0,YR,,F,Y,,,20151205.0,,CN,US,US,2015,Q4,Adult
118233141,11823314,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,1920.0,UG,,,,,21773.0,10.0,UG,INJECTION,BID,2015,Q4,Anaemia,,2015,Q4,1,I,201508.0,20151124.0,20151210,20151210,EXP,,GB-ASTRAZENECA-2015SF19269,ASTRAZENECA,,61.0,YR,,F,Y,66.8,KG,20151210.0,,PH,GB,GB,2015,Q4,Adult
118233141,11823314,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,1920.0,UG,,,,,21773.0,10.0,UG,INJECTION,BID,2015,Q4,Colon cancer,,2015,Q4,1,I,201508.0,20151124.0,20151210,20151210,EXP,,GB-ASTRAZENECA-2015SF19269,ASTRAZENECA,,61.0,YR,,F,Y,66.8,KG,20151210.0,,PH,GB,GB,2015,Q4,Adult
118272751,11827275,18,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,20150416.0,20151029.0,20151211,20151211,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-62633YA",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,117.0,KG,20151211.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Elderly
118272751,11827275,18,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,,,2015,Q4,Cholecystitis acute,,2015,Q4,1,I,20150416.0,20151029.0,20151211,20151211,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-62633YA",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,117.0,KG,20151211.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Elderly
118272751,11827275,18,SS,EXENATIDE,EXENATIDE,1,Unknown,,,,,,,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,1,I,20150416.0,20151029.0,20151211,20151211,EXP,,"US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2015-BI-62633YA",BOEHRINGER INGELHEIM,,70.0,YR,,M,Y,117.0,KG,20151211.0,,MD,COUNTRY NOT SPECIFIED,US,2015,Q4,Elderly
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Chronic kidney disease,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Cold sweat,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Contusion,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Diabetes mellitus,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Dysgeusia,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Haematospermia,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Haemorrhagic diathesis,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Hypertension,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Myocardial infarction,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Off label use,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118315461,11831546,7,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Product use issue,,2015,Q4,1,I,1995.0,20100126.0,20151214,20151214,EXP,,US-ASTRAZENECA-2010BM02558,ASTRAZENECA,,44.0,YR,,M,Y,93.4,KG,20151214.0,,,US,US,2015,Q4,Adult
118436931,11843693,3,C,EXENATIDE,EXENATIDE,1,,"10MCG PEN, DISPOSABLE DEVICE",,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,20151129.0,20071015.0,20151217,20151217,PER,,US-ASTRAZENECA-2007BM17281,ASTRAZENECA,,74.0,YR,,F,Y,104.3,KG,20151217.0,,,US,US,2015,Q4,Elderly
118436931,11843693,3,C,EXENATIDE,EXENATIDE,1,,"10MCG PEN, DISPOSABLE DEVICE",,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Drug dose omission,,2015,Q4,1,I,20151129.0,20071015.0,20151217,20151217,PER,,US-ASTRAZENECA-2007BM17281,ASTRAZENECA,,74.0,YR,,F,Y,104.3,KG,20151217.0,,,US,US,2015,Q4,Elderly
118436931,11843693,3,C,EXENATIDE,EXENATIDE,1,,"10MCG PEN, DISPOSABLE DEVICE",,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Injection site extravasation,,2015,Q4,1,I,20151129.0,20071015.0,20151217,20151217,PER,,US-ASTRAZENECA-2007BM17281,ASTRAZENECA,,74.0,YR,,F,Y,104.3,KG,20151217.0,,,US,US,2015,Q4,Elderly
118436931,11843693,3,C,EXENATIDE,EXENATIDE,1,,"10MCG PEN, DISPOSABLE DEVICE",,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Product quality issue,,2015,Q4,1,I,20151129.0,20071015.0,20151217,20151217,PER,,US-ASTRAZENECA-2007BM17281,ASTRAZENECA,,74.0,YR,,F,Y,104.3,KG,20151217.0,,,US,US,2015,Q4,Elderly
118443671,11844367,8,C,EXENATIDE,EXENATIDE,1,Subcutaneous,"2 MG, OW",,,,,,,,2.0,MG,,/wk,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,1,I,20130125.0,20151006.0,20151217,20151217,EXP,,US-BAYER-2015-445189,BAYER,,56.0,YR,A,M,Y,,,20151217.0,,CN,US,US,2015,Q4,Adult
118495011,11849501,18,C,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Cholecystitis acute,,2015,Q4,1,I,20150416.0,20151207.0,20151218,20151218,EXP,,US-ELI_LILLY_AND_COMPANY-US201512002061,ELI LILLY AND CO,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
118495011,11849501,18,C,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Decreased appetite,,2015,Q4,1,I,20150416.0,20151207.0,20151218,20151218,EXP,,US-ELI_LILLY_AND_COMPANY-US201512002061,ELI LILLY AND CO,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
118495011,11849501,18,C,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,1,I,20150416.0,20151207.0,20151218,20151218,EXP,,US-ELI_LILLY_AND_COMPANY-US201512002061,ELI LILLY AND CO,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
118495011,11849501,18,C,EXENATIDE,EXENATIDE,1,Unknown,"UNK, UNKNOWN",,,,,,,,,,,,2015,Q4,Renal failure,,2015,Q4,1,I,20150416.0,20151207.0,20151218,20151218,EXP,,US-ELI_LILLY_AND_COMPANY-US201512002061,ELI LILLY AND CO,,70.0,YR,,M,Y,117.0,KG,20151217.0,,CN,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Blood glucose decreased,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Blood glucose increased,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Cataract,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Drug administration error,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Early satiety,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Feeling abnormal,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Grief reaction,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Memory impairment,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Nausea,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Post procedural infection,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Stress,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118682831,11868283,5,C,EXENATIDE,EXENATIDE,1,,,,,,,,,,,,SOLUTION FOR INJECTION,,2015,Q4,Weight decreased,,2015,Q4,1,I,2008.0,20080828.0,20151224,20151224,EXP,,US-ASTRAZENECA-2008BM12313,ASTRAZENECA,,70.0,YR,,F,Y,90.7,KG,20151224.0,,,US,US,2015,Q4,Elderly
118691471,11869147,9,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Acute kidney injury,,2015,Q4,1,I,20150416.0,20151218.0,20151226,20151226,EXP,,US-AMGEN-USASP2015136578,AMGEN,,70.0,YR,E,M,Y,117.0,KG,20151226.0,,OT,US,US,2015,Q4,Elderly
118691471,11869147,9,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Cholecystitis acute,,2015,Q4,1,I,20150416.0,20151218.0,20151226,20151226,EXP,,US-AMGEN-USASP2015136578,AMGEN,,70.0,YR,E,M,Y,117.0,KG,20151226.0,,OT,US,US,2015,Q4,Elderly
118691471,11869147,9,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Pancreatitis acute,,2015,Q4,1,I,20150416.0,20151218.0,20151226,20151226,EXP,,US-AMGEN-USASP2015136578,AMGEN,,70.0,YR,E,M,Y,117.0,KG,20151226.0,,OT,US,US,2015,Q4,Elderly
118787511,11878751,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U,,,22200.0,2.0,MG,INJECTION,,2015,Q4,Contraindicated drug administered,,2015,Q4,1,I,,20151222.0,20151230,20151230,EXP,,GB-ASTRAZENECA-2015SF29716,ASTRAZENECA,,61.0,YR,,M,Y,62.0,KG,20151230.0,,OT,GB,GB,2015,Q4,Adult
118787511,11878751,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U,,,22200.0,2.0,MG,INJECTION,,2015,Q4,Cough,,2015,Q4,1,I,,20151222.0,20151230,20151230,EXP,,GB-ASTRAZENECA-2015SF29716,ASTRAZENECA,,61.0,YR,,M,Y,62.0,KG,20151230.0,,OT,GB,GB,2015,Q4,Adult
118787511,11878751,1,PS,EXENATIDE,EXENATIDE,1,Subcutaneous,,,,,U,,,22200.0,2.0,MG,INJECTION,,2015,Q4,Pancreatitis acute,,2015,Q4,1,I,,20151222.0,20151230,20151230,EXP,,GB-ASTRAZENECA-2015SF29716,ASTRAZENECA,,61.0,YR,,M,Y,62.0,KG,20151230.0,,OT,GB,GB,2015,Q4,Adult
118821821,11882182,11,C,EXENATIDE,EXENATIDE,1,Unknown,UNK,,,,,,,,,,,,2015,Q4,Gastrointestinal haemorrhage,,2015,Q4,1,I,20131108.0,20151029.0,20151231,20151231,EXP,,US-BAYER-2015-460694,BAYER,,63.0,YR,A,F,Y,,,20151231.0,,CN,US,US,2015,Q4,Adult
